<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84319</article-id><article-id pub-id-type="doi">10.7554/eLife.84319</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Snf1/AMPK fine-tunes TORC1 signaling in response to glucose starvation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-296269"><name><surname>Caligaris</surname><given-names>Marco</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1732-7694</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-162465"><name><surname>Nicastro</surname><given-names>Raffaele</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5420-2228</contrib-id><email>Raffaele.Nicastro2@unifr.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-153338"><name><surname>Hu</surname><given-names>Zehan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-296270"><name><surname>Tripodi</surname><given-names>Farida</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1246-979X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-296271"><name><surname>Hummel</surname><given-names>Johannes Erwin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-255787"><name><surname>Pillet</surname><given-names>Benjamin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7313-4304</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296272"><name><surname>Deprez</surname><given-names>Marie-Anne</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-74777"><name><surname>Winderickx</surname><given-names>Joris</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3133-7733</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14624"><name><surname>Rospert</surname><given-names>Sabine</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3089-9614</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-296273"><name><surname>Coccetti</surname><given-names>Paola</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5898-5883</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-153334"><name><surname>Dengjel</surname><given-names>Jörn</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9453-4614</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-86485"><name><surname>De Virgilio</surname><given-names>Claudio</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8826-4323</contrib-id><email>Claudio.DeVirgilio@unifr.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/022fs9h90</institution-id><institution>Department of Biology, University of Fribourg</institution></institution-wrap><addr-line><named-content content-type="city">Fribourg</named-content></addr-line><country>Switzerland</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ynf4891</institution-id><institution>Department of Biotechnology and Biosciences, University of Milano-Bicocca</institution></institution-wrap><addr-line><named-content content-type="city">Milano</named-content></addr-line><country>Italy</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0245cg223</institution-id><institution>Institute of Biochemistry and Molecular Biology, Faculty of Medicine, University of Freiburg</institution></institution-wrap><addr-line><named-content content-type="city">Freiburg</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f950310</institution-id><institution>Functional Biology, KU Leuven</institution></institution-wrap><addr-line><named-content content-type="city">Heverlee</named-content></addr-line><country>Belgium</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0245cg223</institution-id><institution>Signalling Research Centres BIOSS and CIBSS, University of Freiburg</institution></institution-wrap><addr-line><named-content content-type="city">Freiburg</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Senior Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>07</day><month>02</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e84319</elocation-id><history><date date-type="received" iso-8601-date="2022-10-25"><day>25</day><month>10</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-02-06"><day>06</day><month>02</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-10-18"><day>18</day><month>10</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.10.18.512649"/></event></pub-history><permissions><copyright-statement>© 2023, Caligaris et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Caligaris et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84319-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-84319-figures-v2.pdf"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.09181" id="ra1"/><abstract><p>The AMP-activated protein kinase (AMPK) and the target of rapamycin complex 1 (TORC1) are central kinase modules of two opposing signaling pathways that control eukaryotic cell growth and metabolism in response to the availability of energy and nutrients. Accordingly, energy depletion activates AMPK to inhibit growth, while nutrients and high energy levels activate TORC1 to promote growth. Both in mammals and lower eukaryotes such as yeast, the AMPK and TORC1 pathways are wired to each other at different levels, which ensures homeostatic control of growth and metabolism. In this context, a previous study (Hughes Hallett et al., 2015) reported that AMPK in yeast, that is Snf1, prevents the transient TORC1 reactivation during the early phase following acute glucose starvation, but the underlying mechanism has remained elusive. Using a combination of unbiased mass spectrometry (MS)-based phosphoproteomics, genetic, biochemical, and physiological experiments, we show here that Snf1 temporally maintains TORC1 inactive in glucose-starved cells primarily through the TORC1-regulatory protein Pib2. Our data, therefore, extend the function of Pib2 to a hub that integrates both glucose and, as reported earlier, glutamine signals to control TORC1. We further demonstrate that Snf1 phosphorylates the TORC1 effector kinase Sch9 within its N-terminal region and thereby antagonizes the phosphorylation of a C-terminal TORC1-target residue within Sch9 itself that is critical for its activity. The consequences of Snf1-mediated phosphorylation of Pib2 and Sch9 are physiologically additive and sufficient to explain the role of Snf1 in short-term inhibition of TORC1 in acutely glucose-starved cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Snf1</kwd><kwd>TORC1</kwd><kwd>AMPK</kwd><kwd>glucose starvation</kwd><kwd>cell signaling</kwd><kwd>proteomics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100020081</institution-id><institution>Canton of Fribourg</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Dengjel</surname><given-names>Jörn</given-names></name><name><surname>De Virgilio</surname><given-names>Claudio</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>310030_166474/184671</award-id><principal-award-recipient><name><surname>De Virgilio</surname><given-names>Claudio</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>310030_184781</award-id><principal-award-recipient><name><surname>Dengjel</surname><given-names>Jörn</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>316030_177088</award-id><principal-award-recipient><name><surname>Dengjel</surname><given-names>Jörn</given-names></name><name><surname>De Virgilio</surname><given-names>Claudio</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003130</institution-id><institution>Fonds Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><award-id>G069413</award-id><principal-award-recipient><name><surname>Winderickx</surname><given-names>Joris</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003130</institution-id><institution>Fonds Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><award-id>G0C7222N</award-id><principal-award-recipient><name><surname>Winderickx</surname><given-names>Joris</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004040</institution-id><institution>Katholieke Universiteit Leuven</institution></institution-wrap></funding-source><award-id>C14/17/063</award-id><principal-award-recipient><name><surname>Winderickx</surname><given-names>Joris</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004040</institution-id><institution>Katholieke Universiteit Leuven</institution></institution-wrap></funding-source><award-id>C14/21/095</award-id><principal-award-recipient><name><surname>Winderickx</surname><given-names>Joris</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100021856</institution-id><institution>Ministero dell'Università e della Ricerca</institution></institution-wrap></funding-source><award-id>2020-ATE-0329</award-id><principal-award-recipient><name><surname>Tripodi</surname><given-names>Farida</given-names></name><name><surname>Coccetti</surname><given-names>Paola</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>Project-ID 403222702 - SFB 1381</award-id><principal-award-recipient><name><surname>Rospert</surname><given-names>Sabine</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>RO 1028/5-2</award-id><principal-award-recipient><name><surname>Rospert</surname><given-names>Sabine</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>TP B08</award-id><principal-award-recipient><name><surname>Rospert</surname><given-names>Sabine</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Discovery of new Snf1/AMPK targets in the TORC1 pathway highlights the complex, multilayered crosstalk between major signaling pathways in the regulation of nutrient deprivation sensing.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The eukaryotic target of rapamycin complex 1 (TORC1/mTORC1) signaling pathway serves as a central hub that couples growth signals with metabolic circuits that define cell growth. The TORC1 protein kinase activity is positively regulated by intracellular nutrients (<italic>e.g</italic>., amino acids, glucose, and lipids), high energy levels, as well as extracellular growth factors (e.g. insulin and insulin-like growth factor 1 [IGF-1]). In response to these cues, it favors the increase of cellular mass by stimulating lipid, nucleotide, and protein synthesis and by inhibiting the autophagic recycling of macromolecules (<xref ref-type="bibr" rid="bib1">Albert and Hall, 2015</xref>; <xref ref-type="bibr" rid="bib35">González and Hall, 2017</xref>; <xref ref-type="bibr" rid="bib57">Laplante and Sabatini, 2012</xref>; <xref ref-type="bibr" rid="bib61">Liu and Sabatini, 2020</xref>). TORC1 function is embedded in as yet incompletely understood feedback loops, allowing it to act as a metabolic rheostat. Uncoupling TORC1 from this regulatory network is associated with dramatically altered lifespan in unicellular organisms such as yeast and with diseases such as cancer, immunodeficiency, type 2 diabetes, and neurodegeneration in humans (<xref ref-type="bibr" rid="bib57">Laplante and Sabatini, 2012</xref>).</p><p>The core structure of TORC1 is highly conserved among eukaryotes and consists of a dimer of a heterotrimeric complex that harbors a TOR serine/threonine protein kinase (Tor1 or Tor2 in the budding yeast <italic>Saccharomyces cerevisiae</italic> or mTOR in mammals) and two regulatory proteins (yeast Kog1 and Lst8, or the orthologous mammalian Raptor [regulatory-associated protein of mTOR] and LST8 [mLST8], respectively <xref ref-type="bibr" rid="bib125">Wullschleger et al., 2006</xref>). Additional non-conserved proteins, such as Tco89 in yeast or the proline-rich Akt substrate of 40 kDa (PRAS40) and the DEP domain-containing mTOR- interacting protein (DEPTOR) in mammals, associate with this core complex to adapt its function to species-specific requirements (<xref ref-type="bibr" rid="bib62">Loewith et al., 2002</xref>; <xref ref-type="bibr" rid="bib83">Peterson et al., 2009</xref>; <xref ref-type="bibr" rid="bib91">Reinke et al., 2004</xref>; <xref ref-type="bibr" rid="bib95">Sancak et al., 2007</xref>). TORC1 mainly functions at the vacuolar/lysosomal surface both in lower eukaryotes like the yeast <italic>S. cerevisiae</italic> as well as in higher eukaryotes such as <italic>Drosophila</italic> and mammals. At this location, TORC1 binds to and/or is regulated by the conserved heterodimeric Rag GTPases (i.e. yeast Gtr1 bound to Gtr2, or mammalian RagA or B bound to RagC or D). These heterodimers associate with structurally conserved protein complexes coined the EGO (exit from rapamycin-induced growth arrest) ternary complex in yeast (EGO-TC; comprising Ego1/Mhe1, Ego2, and Ego3/Slm4) or the pentameric Ragulator complex in mammals (comprising p18, p14, MP1, C7orf59, and HBXIP) (<xref ref-type="bibr" rid="bib5">Bar-Peled et al., 2012</xref>; <xref ref-type="bibr" rid="bib30">Dubouloz et al., 2005</xref>; <xref ref-type="bibr" rid="bib87">Powis et al., 2015</xref>; <xref ref-type="bibr" rid="bib96">Sancak et al., 2010</xref>). The complexes are anchored to vacuolar/lysosomal membranes through N-terminally lipidated Ego1 or p18, respectively (<xref ref-type="bibr" rid="bib10">Binda et al., 2009</xref>; <xref ref-type="bibr" rid="bib73">Nada et al., 2009</xref>; <xref ref-type="bibr" rid="bib87">Powis et al., 2015</xref>; <xref ref-type="bibr" rid="bib96">Sancak et al., 2010</xref>). The Rag GTPases adopt one of two stable conformations, an active state in which Gtr1 or RagA/B is bound to GTP and Gtr2 or RagC/D to GDP, and an inactive state with the opposite GTP/GDP-loading configuration. The respective nucleotide-loading states are primarily preserved by crosstalk between the Rag GTPases and are regulated via a set of conserved GTPase activating (GAP) protein complexes (i.e. yeast SEACIT/mammalian GATOR1 and yeast Lst4-Lst7/mammalian FNIP-FLCN acting on Gtr1/RagA/B and Gtr2/RagC/D, respectively <xref ref-type="bibr" rid="bib6">Bar-Peled et al., 2013</xref>; <xref ref-type="bibr" rid="bib80">Panchaud et al., 2013a</xref>; <xref ref-type="bibr" rid="bib81">Panchaud et al., 2013b</xref>; <xref ref-type="bibr" rid="bib82">Péli-Gulli et al., 2015</xref>; <xref ref-type="bibr" rid="bib84">Petit et al., 2013</xref>; <xref ref-type="bibr" rid="bib101">Shen et al., 2017</xref>; <xref ref-type="bibr" rid="bib114">Tsun et al., 2013</xref>), which mediate cytosolic and/or vacuolar/lysosomal amino acid levels through different mechanisms (<xref ref-type="bibr" rid="bib35">González and Hall, 2017</xref>; <xref ref-type="bibr" rid="bib61">Liu and Sabatini, 2020</xref>; <xref ref-type="bibr" rid="bib75">Nicastro et al., 2017</xref>). Notably, in flies and mammals, but likely not in yeast (<xref ref-type="bibr" rid="bib88">Powis and De Virgilio, 2016</xref>), the Rag-GTPase tethered, lysosome-associated TORC1 pool is also allosterically activated by the small GTPase Rheb (Ras homolog enriched in brain) in its GTP-bound form (<xref ref-type="bibr" rid="bib3">Anandapadamanaban et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Buerger et al., 2006</xref>; <xref ref-type="bibr" rid="bib64">Long et al., 2005</xref>; <xref ref-type="bibr" rid="bib92">Rogala et al., 2019</xref>). Rheb responds, among other factors, to energy levels that are mainly integrated by the Rheb GAP complex (comprising TSC1, TSC2, and TBC1D7), which is also known as Rhebulator (<xref ref-type="bibr" rid="bib27">Demetriades et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Dibble et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Inoki et al., 2003a</xref>; <xref ref-type="bibr" rid="bib64">Long et al., 2005</xref>; <xref ref-type="bibr" rid="bib110">Tee et al., 2003</xref>; <xref ref-type="bibr" rid="bib126">Yang et al., 2017</xref>). This mechanism relies on the AMP-activated protein kinase (AMPK), a key regulator of cellular energy charge that inactivates mTORC1 indirectly by phosphorylating TSC2 and thereby activating the GAP activity of Rhebulator (<xref ref-type="bibr" rid="bib49">Inoki et al., 2003b</xref>; <xref ref-type="bibr" rid="bib100">Shaw et al., 2004</xref>).</p><p>AMPK functions within a conserved heterotrimeric complex encompassing a catalytic α subunit (yeast Snf1 or mammalian α1/2), and one of each β- (yeast Gal83, Sip1, and Sip2 or mammalian β1/2) and γ- (yeast Snf4 or mammalian γ1/2/3) regulatory subunits (<xref ref-type="bibr" rid="bib16">Carling, 2004</xref>; <xref ref-type="bibr" rid="bib34">Ghillebert et al., 2011</xref>; <xref ref-type="bibr" rid="bib43">Hedbacker and Carlson, 2008</xref>). In line with its denomination, mammalian AMPK is allosterically activated by AMP. This seems not to be the case for Snf1, since the latter is mainly activated by the absence of glucose in the medium and since regulatory sites have been characterized that preferably bind ADP instead of AMP (<xref ref-type="bibr" rid="bib21">Coccetti et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Herzig and Shaw, 2018</xref>; <xref ref-type="bibr" rid="bib68">Mayer et al., 2011</xref>; <xref ref-type="bibr" rid="bib123">Wilson et al., 1996</xref>). Nonetheless, both mammalian AMPK and yeast Snf1 are similarly activated by phosphorylation of a conserved threonine (Thr) within their activation loop (yeast Thr<sup>210</sup> or mammalian Thr<sup>172</sup>) that is executed by specific upstream kinases (yeast Sak1, Tos3, and Elm1 or mammalian LKB1 and CaMKK2) (<xref ref-type="bibr" rid="bib36">González et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Hedbacker and Carlson, 2008</xref>). In yeast, this phosphorylation event is reversed by the type I protein phosphatase Glc7 (combined with the regulatory subunit Reg1) specifically when extracellular glucose is sufficiently available (<xref ref-type="bibr" rid="bib66">Ludin et al., 1998</xref>; <xref ref-type="bibr" rid="bib69">McCartney and Schmidt, 2001</xref>). Both AMPK and Snf1 are also wired to control mTORC1/TORC1 via Raptor and Kog1, respectively, albeit through different mechanisms. Accordingly, AMPK has been reported to inhibit mTORC1 through direct phosphorylation of Raptor (<xref ref-type="bibr" rid="bib38">Gwinn et al., 2008</xref>). Although one of the respective AMPK target residues in Raptor is conserved in Kog1, Snf1 does not control TORC1 through this residue (Ser<sup>959</sup>; <xref ref-type="bibr" rid="bib54">Kawai et al., 2011</xref>), but rather through phosphorylation of Ser<sup>491</sup> and Ser<sup>494</sup>, thereby promoting the formation of TORC1-bodies during prolonged glucose starvation (<xref ref-type="bibr" rid="bib47">Hughes Hallett et al., 2015</xref>; <xref ref-type="bibr" rid="bib106">Sullivan et al., 2019</xref>). Notably, the latter process is also regulated by Pib2, a phosphatidylinositol-3-phosphate (PI3P) and Kog1-binding protein that senses glutamine levels and that can both activate and inhibit TORC1 through its C-terminal and N-terminal domains, respectively (<xref ref-type="bibr" rid="bib41">Hatakeyama, 2021</xref>; <xref ref-type="bibr" rid="bib55">Kim and Cunningham, 2015</xref>; <xref ref-type="bibr" rid="bib72">Michel et al., 2017</xref>; <xref ref-type="bibr" rid="bib106">Sullivan et al., 2019</xref>; <xref ref-type="bibr" rid="bib108">Tanigawa and Maeda, 2017</xref>; <xref ref-type="bibr" rid="bib109">Tanigawa et al., 2021</xref>; <xref ref-type="bibr" rid="bib113">Troutman et al., 2022</xref>; <xref ref-type="bibr" rid="bib116">Ukai et al., 2018</xref>; <xref ref-type="bibr" rid="bib119">Varlakhanova et al., 2017</xref>). Finally, Snf1 also plays a role in maintaining TORC1 inactive during the early phase following acute glucose starvation, which is independent of TORC1-body formation, but the underlying mechanism is still elusive (<xref ref-type="bibr" rid="bib47">Hughes Hallett et al., 2015</xref>).</p><p>To address the outstanding question of how Snf1 contributes to TORC1 inhibition following glucose starvation, we used a yeast strain in which Snf1 can be conditionally inactivated by addition of the ATP-analog 2NM-PP1 and applied a mass spectrometry (MS)-based phosphoproteomics strategy that combines in vivo proteomics with on-beads in vitro kinase assays (OBIKA) to identify direct Snf1 target residues on a global scale. This approach not only allowed us to uncover the currently largest set of Snf1-dependent phosphorylation events in <italic>S. cerevisiae</italic>, but also pinpointed several potential Snf1 targets within the TORC1 signaling pathway. Employing genetic, biochemical, and physiological experiments, we demonstrate that Snf1 temporally maintains TORC1 inactive in glucose-starved cells primarily through the regulatory protein Pib2. In addition, Snf1 specifically phosphorylates the TORC1 effector kinase Sch9 and thereby antagonizes the phosphorylation of a C-terminal TORC1-target residue within Sch9 that is critical for its activity. The consequences of Snf1-mediated phosphorylation of Pib2 and Sch9 are physiologically additive and sufficient to mediate an appropriate short-term response of TORC1 to acute glucose starvation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Snf1 prevents transient reactivation of TORC1 in glucose-starved cells</title><p>To study how Snf1 contributes to the inhibition of TORC1 in glucose-starved cells, we used a strain in which the <italic>SNF1</italic> locus expresses the <italic>snf1<sup>I132G</sup></italic> -allele (Snf1<sup>as</sup>) that is sensitive to the ATP-analog 2-naphthylmethyl pyrazolopyrimidine 1 (2NM-PP1) and that supports normal growth on sucrose or low glucose-containing media (<xref ref-type="bibr" rid="bib103">Shirra et al., 2008</xref>; <xref ref-type="bibr" rid="bib127">Zaman et al., 2009</xref>). In our control experiments, the Snf1<sup>as</sup> allele was appropriately activated by its upstream protein kinases, as assessed by the rapid increase in Thr<sup>210</sup> phosphorylation that was comparable to wild-type Snf1, and it mediated the rapid phosphorylation of a synthetic AMPK activity reporter substrate (ACC1-GFP) in glucose-starved cells, albeit to a significantly lower extent than wild-type Snf1 (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>, and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Notably, nitrogen starvation also activates Snf1, but much less than glucose starvation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B, C</xref>). As expected, the presence of 2NM-PP1 fully abrogated the activity of Snf1<sup>as</sup>, but not that of wild-type Snf1 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), while its association with the Snf1<sup>as</sup> kinase active site protected Snf1<sup>as</sup>-pThr<sup>210</sup> from dephosphorylation as reported earlier (<xref ref-type="bibr" rid="bib17">Chandrashekarappa et al., 2013</xref>). Compared to DMSO-treated (control) <italic>snf1<sup>as</sup></italic> cells, 2NM-PP1-treated <italic>snf1<sup>as</sup></italic> cells were also significantly compromised in maintaining TORC1 inactive, as detected by measuring the phosphorylation of Thr<sup>737</sup> in Sch9, a proxy for TORC1 activity (<xref ref-type="bibr" rid="bib117">Urban et al., 2007</xref>), specifically during the time frame of 6–15 min following glucose starvation (<xref ref-type="fig" rid="fig1">Figure 1A–D</xref>). Because loss of Snf1 caused a comparable defect that was independent of the presence or absence of 2NM-PP1 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), our data corroborate the previous notion that Snf1 activity is required for maintaining TORC1 inactive specifically during the early, but not at later, phases of glucose starvation (<xref ref-type="bibr" rid="bib47">Hughes Hallett et al., 2015</xref>). Based on these observations, we reasoned that unscheduled hyperactivation of Snf1 might also inhibit TORC1 even in cells growing in a glucose-rich environment. This was indeed the case as loss of Reg1, the regulatory subunit that instructs the PP1 Glc7 to dephosphorylate pThr<sup>210</sup> and thus inactivate Snf1 (<xref ref-type="bibr" rid="bib66">Ludin et al., 1998</xref>; <xref ref-type="bibr" rid="bib97">Sanz et al., 2000</xref>), resulted in hyperphosphorylation of Snf1-Thr<sup>210</sup> that was accompanied by a significant reduction in TORC1 activity (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). In line with these data, loss of Reg1, like loss of the TORC1-regulatory Rag GTPase Gtr1, rendered cells sensitive to sub-inhibitory levels of rapamycin (as also observed earlier; <xref ref-type="bibr" rid="bib9">Bertram et al., 2002</xref>), while loss of Snf1 conferred slight resistance to rapamycin (<xref ref-type="fig" rid="fig1">Figure 1F</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Snf1 is required for proper downregulation of TORC1 in glucose-starved cells.</title><p>(<bold>A, B</bold>) Wild-type (WT), <italic>snf1Δ</italic>, and <italic>snf1<sup>as</sup></italic> (analog-sensitive) cells were grown exponentially (Exp) and starved for glucose for 10 min (-C) in the absence (-; DMSO vehicle control) or presence (+) of 2NM-PP1. Phosphorylation of the <italic>bona fide</italic> TORC1 target residue Thr<sup>737</sup> in Sch9 and of Thr<sup>210</sup> in Snf1 was detected by immunoblot analyses of whole cell extracts using phospho-specific antibodies against the respective phospho-residues. Anti-Sch9 and anti-His<sub>6</sub> antibodies served to detect the levels of Sch9 and Snf1, respectively (<bold>A</bold>). Notably, binding of 2NM-PP1 to the catalytic cleft of Snf1<sup>as</sup> inhibits its kinase activity and, at the same time, prevents the dephosphorylation of phosphorylated Thr<sup>210</sup> (pThr<sup>210</sup>) in Snf1 (<xref ref-type="bibr" rid="bib17">Chandrashekarappa et al., 2013</xref>). The mean TORC1 activities (<italic>i.e</italic>. Sch9-pThr<sup>737</sup>/Sch9) were quantified, normalized relative to exponentially growing WT cells (set to 1.0), and shown in the bar diagram in (<bold>B</bold>) (n=6; + SEM; unpaired Student’s t-test, ***≤0.0005). (<bold>C, D</bold>) Analog-sensitive <italic>snf1<sup>as</sup></italic> cells were treated as in (<bold>A</bold>), but harvested at the times indicated following glucose starvation (-C). The respective relative TORC1 activities were assessed as in (<bold>B</bold>), but cross-normalized (for each of the two sets of blots) to the same sample from exponentially growing cells (lane 1; Exp), and are shown in (<bold>D</bold>) (n=4; + SEM; unpaired Student’s t-test, *p≤0.05, **p≤0.005). (<bold>E</bold>) WT and <italic>reg1∆</italic> cells were grown exponentially and assayed for their mean relative TORC1 activities (Sch9-pThr<sup>737</sup>/Sch9) and Snf1-Thr<sup>210</sup> phosphorylation levels (Snf1-pThr<sup>210</sup>/Snf1), each normalized to WT cells (set to 1.0; n=4; ± SEM). In unpaired Student’s tests, both values in <italic>reg1∆</italic> cells were significantly different from the ones in WT cells (***p≤0.0005, ****p≤0.00005). (<bold>F</bold>) Exponentially growing cells (of the indicated genotype) were 10-fold serially diluted, spotted on synthetic complete medium containing, or not (control), 3 nM rapamycin, and grown for 3 days at 30 °C (n=3). The online version of this article includes the following source data for <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>, quantification of blots for graphs shown in (<bold>B, D and E</bold>); <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>, uncropped blots shown in (<bold>A, C and E</bold>); Uncropped dropspots shown in (<bold>F</bold>); <xref ref-type="supplementary-material" rid="fig1sdata3">Figure 1—source data 3</xref>, raw blots shown in (<bold>A, C and E</bold>) and raw dropspots shown in (<bold>F</bold>).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Quantification of blots for graphs shown in B, D, E.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84319-fig1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Uncropped blots shown in A, C, E and uncropped dropspots shown in F.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84319-fig1-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Raw blots shown in A, C, E and raw dropspots shown in F.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig1-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Specificity of 2NM-PP1 and differential Snf1 activation upon nitrogen and carbon starvation.</title><p>(<bold>A</bold>) 2NM-PP1 treatment inhibits Snf1<sup>as</sup> activity in vivo. WT and ATP-analogue-sensitive <italic>snf1<sup>as</sup></italic> cells expressing a plasmid-encoded synthetic reporter of Snf1 activity that is based on a rat ACC1 peptide (ACC1-GFP; <xref ref-type="bibr" rid="bib25">Deroover et al., 2016</xref>) were grown exponentially (Exp) and then starved for 2, 5, and 15 min for glucose (-C) and treated with vehicle (-; DMSO) or 2NM-PP1 (+). Immunoblot analyses were performed as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>, except that anti-GFP and anti-ACC1-pSer<sup>79</sup> were additionally used to detect the levels of ACC1-GFP and the phosphorylation state of the Snf1/AMPK target residue in ACC1-GFP that corresponds to Ser<sup>79</sup> in rat ACC1 (n=3). (<bold>B, C</bold>) Activation of Snf1 following glucose or nitrogen starvation. Wild-type cells (as in (<bold>A</bold>)) were grown exponentially (Exp), or starved for nitrogen (-N; 10 min), or glucose (-C; 10 min) and subjected to immunoblot analyses (<bold>B</bold>). The mean relative TORC1 (Sch9-pThr<sup>737</sup>/Sch9) and Snf1 activities (i.e. Snf1-pThr<sup>210</sup>/Snf1 and ACC1-GFP-pSer<sup>79</sup>/ACC1-GFP) were quantified, normalized relative to exponentially growing WT cells (set to 1.0), and shown in the bar diagrams in (<bold>C</bold>) (n=3; + SEM; unpaired Student’s t-test, *≤0.05, **p≤0.005, ***p≤0.0005, ****p≤0.00005). The online version of this article includes the following source data for <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>, quantification of blots for graphs shown in (<bold>C</bold>); in <xref ref-type="supplementary-material" rid="fig1s1sdata2">Figure 1—figure supplement 1—source data 2</xref>, uncropped blots shown in (<bold>A and B</bold>); <xref ref-type="supplementary-material" rid="fig1s1sdata3">Figure 1—figure supplement 1—source data 3</xref>, raw blots shown in (<bold>A and B</bold>).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Quantification of blots for graphs shown in C.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84319-fig1-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Uncropped blots shown in A, B.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84319-fig1-figsupp1-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Raw blots shown in A, B.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig1-figsupp1-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig1-figsupp1-v2.tif"/></fig></fig-group><p>It has previously been demonstrated that TORC1 activity can be transiently (on a short-time scale of 1–5 min) activated by the addition of a nitrogen source such as glutamine to nitrogen starved cells (<xref ref-type="bibr" rid="bib105">Stracka et al., 2014</xref>). Based on our results above, we therefore assumed that the respective transient activation of TORC1 may be reduced in the absence of glucose, because we expected this to activate Snf1 and therefore (directly or indirectly) inhibit TORC1. Indeed, when <italic>snf1<sup>as</sup></italic> cells were starved for both glucose and glutamine at the same time, TORC1 was rapidly inactivated and could only be transiently reactivated when cells were refed with either glucose alone or with glucose and glutamine combined (<xref ref-type="fig" rid="fig2">Figure 2A–D</xref>), but not when refed with glutamine alone (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>). In the latter case, however, 2NM-PP1 treatment, and hence inactivation of Snf1<sup>as</sup>, was able to partially restore the transient glutamine-mediated TORC1 activation (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>). From these experiments, we infer that Snf1 not only contributes to proper TORC1 inhibition in glucose-starved cells, but also helps to prevent the transient reactivation of TORC1 in glutamine refed, glucose-starved cells.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Snf1 prevents transient TORC1 restimulation by glutamine in glucose- and glutamine-starved cells.</title><p>(<bold>A–F</bold>) Exponentially growing <italic>snf1<sup>as</sup></italic> cells were starved for 20 min for nitrogen and glucose (-N, -C) and then restimulated for the times indicated, in the absence (DMSO) or presence of 2NM-PP1, with 2% glucose (Glc) (<bold>A, B</bold>), 2% glucose and 3.3 mM glutamine (Gln) (<bold>C, D</bold>), or 3.3 mM glutamine (<bold>E, F</bold>). Immunoblot analyses were performed as in <xref ref-type="fig" rid="fig1">Figure 1A</xref> and the relative TORC1 activities in (<bold>A</bold>), (<bold>C</bold>), and (<bold>E</bold>), were quantified as in <xref ref-type="fig" rid="fig1">Figure 1B</xref> and are shown in (<bold>B</bold>), (<bold>D</bold>), and (<bold>F</bold>), respectively (n=3; + SEM; unpaired Student’s t-test, *p≤0.05, ***p≤0.0005). The online version of this article includes the following source data for <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>, quantification of blots for graphs shown in (<bold>B, D and F</bold>); <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>, uncropped blots shown in (<bold>A, C and E</bold>); <xref ref-type="supplementary-material" rid="fig2sdata3">Figure 2—source data 3</xref>, raw blots shown in (<bold>A, C and E</bold>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Quantification of blots for graphs shown in B, D and F.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84319-fig2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Uncropped blots shown in A, C and E.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84319-fig2-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Raw blots shown in A, C and E.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig2-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig2-v2.tif"/></fig></sec><sec id="s2-2"><title>Global phosphoproteomics identifies potential Snf1 targets within the TORC1 signaling pathway</title><p>To dissect the mechanisms by which Snf1 impinges on TORC1 signaling, we decided to perform a set of stable isotope-labeling by amino acids in cell culture (SILAC)-based quantitative phosphoproteomic experiments, similarly as recently described (<xref ref-type="bibr" rid="bib46">Hu et al., 2021</xref>). For in vivo analyses, <italic>snf1<sup>as</sup></italic> cells were grown in three different SILAC media supporting the comparison of three experimental conditions (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Cells grown in full medium (2% glucose, light label) served as control. The cellular response to glucose starvation was analyzed after 5 and 15 min (shift to 0.05% glucose, medium and heavy label, respectively). To discriminate potential Snf1 target sites from sites being regulated by other kinases, concomitantly to the glucose downshift, cells were treated, or not, with the selective ATP-competitive inhibitor 2NM-PP1. Snf1 target sites should be positively regulated in the control set and not, or significantly less, in the 2NM-PP1-treated set (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; n=5 biological replicates per set). To further discriminate direct from indirect effects, we performed whole proteome on bead in vitro kinase assays (OBIKA) comparing the immobilized proteome of <italic>snf1<sup>as</sup></italic> cells (growing exponentially in the presence of 5% glucose and ATP analog) incubated with purified wild-type Snf1 to that incubated with a kinase-inactive Snf1<sup>T210A</sup> mutant (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; n=5 biological replicates) (<xref ref-type="bibr" rid="bib46">Hu et al., 2021</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Quantitative phosphoproteomic analyses for the identification of potential Snf1 target sites.</title><p>(<bold>A</bold>) Quantitative MS-based proteomics workflow (SILAC n=5, OBIKA n=5). (<bold>B</bold>) Histogram of the number of identified phosphosites in the SILAC analysis after each filtering step and the relative amount of phosphosites attributed to classes I and II among the significant ones. (<bold>C</bold>) Proportional Venn diagram highlighting the commonly identified phosphosites in the current and two recent Snf1 phosphoproteomic studies. (<bold>D</bold>) Heatmap of phosphosite kinetics. Normalized SILAC ratios (treated <italic>versus</italic> untreated) of class I and class II sites (highlighted in B) were log2 transformed and z normalized prior unsupervised hierarchical clustering of the rows tree using Euclidean distance as matrix. Five major clusters <italic>a-e</italic>, each highlighted by a different color, are observed. (<bold>E</bold>) Motif analyses of Snf1 phosphosites identified by in vivo SILAC and OBIKA experiments as outlined in (<bold>A</bold>). (<bold>F</bold>) Protein-protein interaction network comprising 57 interconnected proteins out of the 98 where at least one Snf1-dependent phosphosite was shortlisted by the intersection of the SILAC and OBIKA analyses. The network was generated with Cytoscape using the STRING plugin, setting the confidence (score) cut-off at 0.25. Edge thickness represents the score value of each interaction. (<bold>G</bold>) Schematic model representing components of the Snf1/AMPK and TORC1 signaling pathways that contain Snf1-regulated phosphosites. Phosphosites attributed to class II are highlighted with a bold-pink outline. The three Snf1 β-subunits are represented with a dashed outline on the left. Solid and dashed arrows refer to direct and indirect activating interactions, respectively. Dashed lines with bars refer to potential (question marks) inhibitory interactions that are experimentally addressed in the indicated figures in this study. Source data for this figure are provided in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Specific motif analyses of Snf1 phosphosites and role of Lst4 in TORC1 reactivation in glucose-starved, Snf1-inhibited cells.</title><p>(<bold>A, B</bold>) Motif analyses of Snf1 phosphosites identified by both in vivo SILAC and OBIKA experiments and only responding after 5 min (<bold>A</bold>) and 15 min (<bold>B</bold>). (<bold>C</bold>) Lst4 does not mediate TORC1 reactivation in glucose-starved, Snf1-inhibited cells. Exponentially growing <italic>snf1<sup>as</sup></italic> or <italic>snf1<sup>as</sup> lst4∆</italic> cells (Exp) were starved for glucose (-C; 10 min) in the presence of vehicle (-; DMSO) or 2NM-PP1 (+), and analyzed as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. The mean TORC1 activities (i.e. Sch9-pThr<sup>737</sup>/Sch9) were quantified, normalized relative to exponentially growing <italic>snf1<sup>as</sup></italic> cells (set to 1.0), and shown below the Sch9 input blot (n=3; ± SEM). The online version of this article includes the following source data for <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>, quantification of blots for values shown in (<bold>C</bold>); <xref ref-type="supplementary-material" rid="fig3s1sdata2">Figure 3—figure supplement 1—source data 2</xref>, uncropped blots shown in (<bold>C</bold>); <xref ref-type="supplementary-material" rid="fig3s1sdata3">Figure 3—figure supplement 1—source data 3</xref>, raw blots shown in (<bold>C</bold>).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Quantification of blots for values shown in C.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84319-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Uncropped blots shown in C.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84319-fig3-figsupp1-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata3"><label>Figure 3—figure supplement 1—source data 3.</label><caption><title>Raw blots shown in C.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig3-figsupp1-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig3-figsupp1-v2.tif"/></fig></fig-group><p>In vivo analyses led to the identification of 40’547 phosphosites, of which 34’747 could be quantified (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). After stringent filtering, we used 21’223 sites, which clearly localized to a specific amino acid residue (localization probability &gt;0.75) (<xref ref-type="bibr" rid="bib78">Olsen et al., 2006</xref>; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2A-B</xref>), for statistical analyses to identify potential Snf1 target sites. Class I target sites had to fulfill two criteria: sites had to be significantly upregulated (i) when using a random effect model comparing starved (5 min and 15 min) to non-starved cells (p&lt;0.05); and (ii) when comparing starved cells to cells treated additionally with the inhibitor 2NM-PP1 (Student’s t-test, FDR&lt;0.05). Class II target sites had only to fulfill the second criterium. Class II sites contained target residues such as Ser<sup>1157</sup> in Acc1, the cytosolic acetyl-CoA carboxylase that is already phosphorylated by Snf1 in cells grown on 2% glucose, but dephosphorylated upon 2NM-PP1-mediated inhibition of Snf1<sup>as</sup> (<xref ref-type="bibr" rid="bib13">Braun et al., 2014</xref>). In total, this led to a shortlist of 1409 sites, divided into 984 class I sites and 425 class II sites (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2C</xref>). Our shortlisted class I and class II sites cover between 26% and 53% of the previously published potential Snf1 target sites (<xref ref-type="bibr" rid="bib13">Braun et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Kanshin et al., 2017</xref>; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2D</xref>), overlapping to a larger extent with the respective studies than the studies with each other (<xref ref-type="fig" rid="fig3">Figure 3</xref>). In addition, we expand the potential Snf1 target repertoire by more than 1200 sites highlighting the resource character of the current study. We performed hierarchically clustering to characterize the kinetic behavior of sites and observed five major clusters (<xref ref-type="fig" rid="fig3">Figure 3D</xref>): cluster <italic>a</italic> contains sites that responded transiently after 5 min of stimulation; clusters <italic>b</italic>, <italic>c</italic>, and <italic>e</italic> contain sites that responded in a sustained manner after 5 min and 15 min; and cluster <italic>d</italic> contains responders that reacted only after 15 min. Source proteins of cluster <italic>a</italic> relate to ‘regulation of growth’, amongst them the Snf1 target Mig1, while those in clusters <italic>b</italic>, <italic>c</italic>, and <italic>e</italic> are linked to ‘cell cycle, transcription, endocytosis, and proteins transport’, such as the zinc-finger and Snf1 target protein Msn4, and those in cluster <italic>d</italic> are enriched in ‘serine-threonine kinases’, like Atg1 and Sch9 (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2E</xref>).</p><p>To discriminate potential indirect effects observed in vivo from direct Snf1 targets, we overlaid the significantly regulated sites from the SILAC and OBIKA datasets. Of the 986 commonly identified and quantified sites, 145 sites on 98 source proteins were significantly regulated by both approaches, characterizing them as <italic>bona fide</italic> Snf1 target sites (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2F</xref>). The consensus motif of these sites corroborates the published AMPK and Snf1 motif with two basic amino acid residues in the –3 and –4 positions and a hydrophobic leucine residue in the +4 position (<xref ref-type="fig" rid="fig3">Figure 3E</xref>; <xref ref-type="bibr" rid="bib24">Dale et al., 1995</xref>; <xref ref-type="bibr" rid="bib38">Gwinn et al., 2008</xref>; <xref ref-type="bibr" rid="bib98">Schaffer et al., 2015</xref>; <xref ref-type="bibr" rid="bib99">Scott et al., 2002</xref>). As such, this further supports our interpretation that these sites are <italic>bona fide</italic> Snf1 target sites. Notably, of the 145 confirmed target sites, 81 (i.e. 72%) were significantly regulated after both 5 min and 15 min. Of the remaining 64 sites, 32 responded only after 5 min, while the other 32 responded only after 15 min. Some of the former residues are located within Snf1 itself, the β-subunit of the Snf1 complex (i.e. Sip1), the Snf1-targeting kinase Sak1, and Mig1, while some of the latter are located within the known Snf1-interacting proteins such as Gln3, Msn4, and Reg1. These observations indicate that Snf1-dependent phosphorylation initiates, as expected, within the Snf1 complex and then progresses to other effectors. Interestingly, based on the residues that responded exclusively after 5 min, we retrieved a perfect Snf1 consensus motif (i.e. an arginine residue in the –3 position and a leucine residue in the +4 position; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). The one retrieved for the residues that respond exclusively at 15 min, in contrast, significantly deviated from this consensus motif (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). The temporal deferral of some Snf1 target phosphorylation events may therefore perhaps be in part be explained by reduced substrate affinity due to consensus motif divergence.</p><p>As a kinase generally regulates multiple proteins within a given pathway, we analyzed known protein-protein interactions of the 98 Snf1 target proteins in STRING DB, enabling us to generate a network of 57 proteins (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; <xref ref-type="bibr" rid="bib107">Szklarczyk et al., 2021</xref>). In line with the significant overlap of our data with the ones published by <xref ref-type="bibr" rid="bib13">Braun et al., 2014</xref>, this network covers similar biological processes including intracellular trafficking, ribosome biogenesis, translation, mRNA metabolism, inositol phosphate metabolism, chromatin remodeling, and TORC1 signaling (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Gratifyingly, this network also includes most of the previously known proximal Snf1 targets including for instance Ccr4 (<xref ref-type="bibr" rid="bib13">Braun et al., 2014</xref>), Cyr1/Cdc35 (<xref ref-type="bibr" rid="bib74">Nicastro et al., 2015</xref>), Eap1 (<xref ref-type="bibr" rid="bib13">Braun et al., 2014</xref>). Gat1 (<xref ref-type="bibr" rid="bib56">Kulkarni et al., 2006</xref>), Gln3 (<xref ref-type="bibr" rid="bib9">Bertram et al., 2002</xref>; <xref ref-type="bibr" rid="bib56">Kulkarni et al., 2006</xref>), Mig1 (<xref ref-type="bibr" rid="bib28">DeVit and Johnston, 1999</xref>; <xref ref-type="bibr" rid="bib79">Ostling and Ronne, 1998</xref>; <xref ref-type="bibr" rid="bib104">Smith et al., 1999</xref>; <xref ref-type="bibr" rid="bib112">Treitel et al., 1998</xref>), Msn4 (<xref ref-type="bibr" rid="bib32">Estruch and Carlson, 1993</xref>; <xref ref-type="bibr" rid="bib85">Petrenko et al., 2013</xref>), and Rod1 (<xref ref-type="bibr" rid="bib2">Alvaro et al., 2016</xref>; <xref ref-type="bibr" rid="bib58">Laussel et al., 2022</xref>; <xref ref-type="bibr" rid="bib77">O’Donnell and Schmidt, 2019</xref>; <xref ref-type="bibr" rid="bib102">Shinoda and Kikuchi, 2007</xref>). In addition, the dataset also pinpoints potential Snf1 target residues in numerous proteins that have an assigned function as Snf1 effectors such as Aly2 and Bul2 (<xref ref-type="bibr" rid="bib12">Bowman et al., 2022</xref>; <xref ref-type="bibr" rid="bib77">O’Donnell and Schmidt, 2019</xref>; <xref ref-type="bibr" rid="bib90">Ptacek et al., 2005</xref>), Glo3 (<xref ref-type="bibr" rid="bib4">Arakel et al., 2019</xref>), Gpd2 (<xref ref-type="bibr" rid="bib59">Lee et al., 2012</xref>), and Npr1 (<xref ref-type="bibr" rid="bib14">Brito et al., 2019</xref>). Finally, Snf1-regulated residues were also identified in the Snf1-β-subunits Gal83 and Sip2 (<xref ref-type="bibr" rid="bib16">Carling, 2004</xref>; <xref ref-type="bibr" rid="bib43">Hedbacker and Carlson, 2008</xref>), the Sak1 kinase that phosphorylates Snf1-Thr<sup>210</sup> (<xref ref-type="bibr" rid="bib36">González et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Hedbacker and Carlson, 2008</xref>), the PP1 phosphatase Glc7-regulatory subunit Reg1 and the protein phosphatase C Ptc1 that share an overlapping role in the dephosphorylation of Snf1-pThr<sup>210</sup> (<xref ref-type="bibr" rid="bib66">Ludin et al., 1998</xref>; <xref ref-type="bibr" rid="bib69">McCartney and Schmidt, 2001</xref>; <xref ref-type="bibr" rid="bib93">Ruiz et al., 2013</xref>), and Snf1 itself. These observations indicate that Snf1 is embedded and engaged in an elaborated feedback control network, which, based on our current data, can be experimentally addressed in the future.</p><p>As briefly mentioned above, our in vivo phosphoproteomic analyses also pinpointed several Snf1-regulated residues within proteins that act in the TORC1 signaling pathway, including Lst4 and Pib2 that function upstream of TORC1, the TORC1 subunits Kog1 and Tco89, and the proximal TORC1 effector Sch9 (<xref ref-type="bibr" rid="bib117">Urban et al., 2007</xref>; <xref ref-type="fig" rid="fig3">Figure 3G</xref>). From these 5 TORC1-related hits, we excluded Kog1 from further analyses because the potential Snf1 target residue in Kog1 that we identified was Ser<sup>491</sup>, and mutation of this residue has previously been found not to affect the capacity of cells to maintain TORC1 inactive during the early phase of glucose starvation (<xref ref-type="bibr" rid="bib47">Hughes Hallett et al., 2015</xref>; <xref ref-type="bibr" rid="bib106">Sullivan et al., 2019</xref>). We have also not given priority to the analysis of Tco89, since it is a heavily phosphorylated protein (&gt;70 phosphorylated residues) that we intend to dissect separately in parallel studies. Finally, we also did not follow up on the TORC1-stimulating protein Lst4. The reason for this is that loss of Lst4 did not significantly change the transient reactivation of TORC1 in glucose-starved, 2NM-PP1-treated <italic>snf1<sup>as</sup></italic> cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), even though it reduced the TORC1 activity in exponentially growing cells as reported (<xref ref-type="bibr" rid="bib82">Péli-Gulli et al., 2015</xref>). Thus, we focused our subsequent experiments on the two remaining proteins, namely Pib2 and Sch9, and examined in more detail the consequences of their phosphorylation by Snf1 for signaling via the TORC1 pathway.</p></sec><sec id="s2-3"><title>Snf1 phosphorylates Pib2-Ser<sup>268,309</sup> to weaken its association with Kog1</title><p>Our phosphoproteomic approach identified two potential Snf1 target residues each within the Kog1-binding region of Pib2, Ser<sup>268</sup> and Ser<sup>309</sup>, of which the latter was also detected by OBIKA with Snf1 (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2C-F</xref>). To further corroborate these data, we carried out an in vitro Snf1 kinase assay using an N-terminally truncated Pib2 fragment as substrate, which, unlike full-length Pib2, could be stably expressed in and purified from bacteria. Accordingly, wild-type Snf1 (purified from yeast), but not the kinase-inactive Snf1<sup>T210A</sup>, was able to phosphorylate the Pib2 fragment. We also introduced mutations of Ser<sup>268</sup> and Ser<sup>309</sup> in the Pib2 fragment and replaced them with alanine (Ala) residues. The fragments carrying either one of these mutations were still phosphorylated by wild-type Snf1, though to a different extent, but when both mutations were combined, the phosphorylation level dropped significantly (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Together with our finding that the Snf1 complex was able to bind Pib2 in microscale thermophoresis assays (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), our data therefore, led us to infer that Snf1 may control Pib2 function primarily through phosphorylation of the Ser<sup>268</sup> and Ser<sup>309</sup> residues.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Snf1 weakens the Pib2-Kog1 association by phosphorylating Pib2-Ser<sup>268,309.</sup></title><p>(<bold>A</bold>) Schematic representation of the structure of Pib2 with the N-terminal TORC1-inhibitory (NID), Kog1-binding (Kog1-BD), phosphatidylinositol-3-phosphate (PI3P) -binding Fab1-YOTB-Vac1-EEA1 (FYVE), and C-terminal TORC1-activatory (CAD) domains (<xref ref-type="bibr" rid="bib41">Hatakeyama, 2021</xref>). The residues Ser<sup>268</sup> and Ser<sup>309</sup> in Pib2 were both identified as potential Snf1 targets (P) in vivo (SILAC), while only Ser<sup>309</sup> was recovered in our highly multiplexed on-beads in vitro kinase assays (OBIKA) with Snf1. (<bold>B, C</bold>) Snf1 controls the phosphorylation of Ser<sup>268</sup> and Ser<sup>309</sup> in Pib2 in vivo. Phosphorylation levels of Pib2-Ser<sup>268</sup> (<bold>B</bold>) and Pib2-Ser<sup>309</sup> (<bold>C</bold>) in untreated (DMSO) and 2NM-PP1-treated <italic>snf1<sup>as</sup></italic> cells that were grown exponentially (Exp) and limited for glucose (0.05%) for the times indicated. Mean values were extracted from the SILAC experiment (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>) and normalized to the ones in exponentially growing cells (set to 1.0) (n=3; + SD; unpaired Student’s t-test, *FDR ≤ 0.05). (<bold>D</bold>) Snf1 phosphorylates Ser<sup>268</sup> and Ser<sup>309</sup> in Pib2 in vitro. Snf1 (WT) and kinase-inactive Snf1<sup>T210A</sup> (TA) were purified from yeast and used in protein kinase assays with [γ-<sup>32</sup>P]-ATP and a bacterially-expressed fragment of Pib2 (Pib2<sup>221-635</sup>) lacking the N-terminal 220 amino acids that, according to our in vivo proteomics analyses, did not contain a potential Snf1 target residue. In parallel protein kinase assays, we also used the respective Pib2<sup>S268A</sup>, Pib2<sup>S309A</sup>, and Pib2<sup>S268A/S309A</sup> (Pib2<sup>SASA</sup>) mutant fragments as substrates. Substrate phosphorylation was detected by autoradiography (<sup>32</sup>P, lower panel) and Sypro Ruby (SyR) staining is shown as loading control for the Snf1 variants (upper panel) and the His<sub>6</sub>-tagged Pib2 fragments that were partially degraded and ran in more than 1 band (panel in the middle). The mean phosphorylation of Pib2<sup>S268A</sup>, Pib2<sup>S309A</sup>, and Pib2<sup>S268A/S309A</sup> (Pib2<sup>SASA</sup>) fragments by wild-type Snf1 (i.e. <sup>32</sup>P signal/Sypro Ruby [SyR] substrate input level [including the indicated faster migrating proteolytic forms]; nd, not detected) was assessed relative to the one of the Pib2<sup>WT</sup> fragment (set to 1.0; n=3; ± SEM; unpaired Student’s t-test, ***p≤0.0005, ****p≤0.00005). (<bold>E</bold>) The Snf1 complex binds Pib2. The binding affinity between bacterially purified, titrated Pib2<sup>221-635</sup> and yeast purified Snf1 complex (containing the C-terminally GFP-tagged Snf4 γ-subunit) was assessed by microscale thermophoresis. The dissociation constant (K<sub>D</sub>; 95% profile likelihood = 136–1098 nM, n=3; ± SEM) was calculated using a nonlinear asymmetric sigmoidal regression. (<bold>F, G</bold>) Expression of the phosphomimetic Pib2<sup>S268E,S309E</sup> allele, like loss of Pib2, rescues the TORC1 inactivation defect in glucose-starved, Snf1-compromised cells. Exponentially growing <italic>snf1<sup>as</sup></italic>, <italic>snf1<sup>as</sup> pib2∆</italic>, <italic>snf1<sup>as</sup> pib2<sup>S268A,S309A</sup></italic> (<italic>pib2<sup>SASA</sup></italic>), and <italic>snf1<sup>as</sup> pib2<sup>S268E,S309E</sup></italic> (<italic>pib2<sup>SESE</sup></italic>) cells were grown exponentially (Exp) and then starved for 10 min for glucose (-C) in the absence (-; DMSO) or the presence (+) of 2NM-PP1. Immunoblot analyses of Sch9-pThr<sup>737</sup> and Sch9 (left blots) and of Snf1<sup>as</sup>-pThr<sup>210</sup> and Snf1<sup>as</sup> (right blots) were carried out as in <xref ref-type="fig" rid="fig1">Figure 1A</xref> (<bold>F</bold>). The mean relative TORC1 activities in the four strains were quantified as in <xref ref-type="fig" rid="fig1">Figure 1B</xref> and normalized to the values in exponentially growing <italic>snf1<sup>as</sup></italic> cells (set to 1.0; n=4; + SEM; unpaired Student’s t-test, *p≤0.05, **p≤0.005, ***p≤0.0005) (<bold>G</bold>). (<bold>H</bold>) The phosphomimetic Pib2<sup>S268E,S309E</sup> is compromised for TORC1-binding. Kog1-HA<sub>3</sub>-expressing cells co-expressing Pib2-myc<sub>13</sub> (WT), Pib2<sup>S368A,S309A</sup>-myc<sub>13</sub> (SASA), Pib2<sup>S368E,S309E</sup>-myc<sub>13</sub> (SESE), or untagged Pib2 (-) were grown exponentially. Lysates (input) containing 60 mM glutamine and anti-myc immunoprecipitates (IP: anti-myc) were analyzed by immunoblotting with anti-HA and anti-myc antibodies, respectively. The mean relative amount of Kog1-HA<sub>3</sub> that was immunoprecipitated with Pib2-myc<sub>13</sub> and its variants was determined and normalized to the one between Kog1-HA<sub>3</sub> and Pib2-myc<sub>13</sub> (set to 1.0; n=4; + SEM; unpaired Student’s t-test, *p≤0.05; nd, not detected). (<bold>I</bold>) Pib2-myc<sub>13</sub> alleles are adequately expressed. Expression of Pib2-myc<sub>13</sub> variants (as in F) was probed by immunoblot analysis in extracts of exponentially growing cells using anti-myc antibodies. Values were quantified relative to Adh1 levels (detected with anti-Adh1 antibodies) and normalized to the respective Pib2-myc<sub>13</sub>/Adh1 ratio in cells expressing the WT Pib2-myc<sub>13</sub> (n=3; ± SEM; unpaired Student’s t-test; nd, not detected). The online version of this article includes the following source data for <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>, data for the graph shown in (<bold>B, C and E</bold>) and quantifications of the blots in (<bold>D, H and I</bold>) and for the graph shown in (<bold>G</bold>); <xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>, uncropped blots, gels and autoradiographies shown in (<bold>D, F, H and I</bold>); <xref ref-type="supplementary-material" rid="fig4sdata3">Figure 4—source data 3</xref>, raw blots, gels and autoradiographies shown in (<bold>D, F, H and I</bold>).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Data for the graph shown in B, C and E and quantifications of the blots in D, H and I and for the graph shown in G.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84319-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Uncropped blots, gels and autoradiographies shown in D, F, H and I.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84319-fig4-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Raw blots, gels and autoradiographies shown in D, F, H and I.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig4-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig4-v2.tif"/></fig><p>To address the physiological role of Ser<sup>268/309</sup> phosphorylation in Pib2, we next studied the response to short-term glucose starvation of 2NM-PP1-treated and -untreated <italic>snf1<sup>as</sup></italic> strains that expressed either the phosphomutant Pib2<sup>S268A,S309A</sup> or the phosphomimetic Pib2<sup>S268E,S309E</sup>. The <italic>snf1<sup>as</sup></italic> strain in which <italic>PIB2</italic> was deleted served as control. Interestingly, expression of Pib2<sup>S268E,S309E</sup> or loss of Pib2, but not the expression of Pib2<sup>S268A,S309A</sup>, rendered TORC1 more sensitive to glucose-starvation in DMSO-treated control cells and largely suppressed the unscheduled reactivation of TORC1 in glucose-starved cells in which Snf1<sup>as</sup> was inhibited by a 2NM-PP1-treatment (<xref ref-type="fig" rid="fig4">Figure 4F and G</xref>). The observation that loss of Pib2 and expression of the Pib2<sup>S268E,S309E</sup> allele similarly affect TORC1 activity suggests that the latter allele may be compromised in a TORC1 activating mechanism. The Snf1-dependent phosphorylation of Pib2 may therefore possibly compromise the function of the C-terminal TORC1-activating domain (CAD) rather than the N-terminal TORC1-inhibitory domain (NID). Consequently, loss of Snf1, would allow the Pib2-CAD to transiently activate TORC1 in glucose-starved cells.</p><p>Notably, as a readout for TORC1 activity, we monitored the phosphorylation of the downstream effector kinase Sch9, which as mentioned above and further explained below, is itself a potential direct Snf1 substrate. Therefore, we sought to understand how Pib2 phosphorylation may affect TORC1 signaling. We noticed that the Ser<sup>268</sup> and Ser<sup>309</sup> Snf1 target sites reside within the Kog1-binding domains of Pib2 (<xref ref-type="bibr" rid="bib72">Michel et al., 2017</xref>; <xref ref-type="bibr" rid="bib106">Sullivan et al., 2019</xref>; <xref ref-type="bibr" rid="bib113">Troutman et al., 2022</xref>), which led us to speculate that the phosphorylation state of these residues could affect the Pib2-Kog1 association. To this end, we performed co-immunoprecipitation assays and found that this was indeed the case, as we observed that the Pib2<sup>S268E,S309E</sup> variant exhibited significantly reduced affinity for Kog1 when compared to wild-type Pib2 or Pib2<sup>S268A,S309A</sup> (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Importantly, immunoblot analyses of the myc-tagged phosphomutant and phosphomimetic Pib2 variants showed that the introduction of the respective mutations in Pib2 did not affect the stability of the proteins (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Thus, the combined data led us to conclude that Snf1 activation in glucose-starved cells mediates temporal TORC1 inhibition primarily through phosphorylation of Pib2 at Ser<sup>268/309</sup>, which serves to weaken the association between Pib2 and Kog1 and prevent it from activating TORC1 under these conditions.</p></sec><sec id="s2-4"><title>Snf1 constrains Sch9-Thr<sup>737</sup> phosphorylation by targeting Sch9-Ser<sup>288</sup></title><p>Our phosphoproteomic approach also identified one potential Snf1 target residue, namely Ser<sup>288</sup>, that lies within the C2 domain of Sch9 (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>, and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2C, F</xref>). Like for Pib2, we tried to corroborate these data using in vitro Snf1 kinase assays and an N-terminal fragment of Sch9 as substrate, which, unlike full-length Sch9, could be stably expressed in and purified from bacteria. Here too, wild-type Snf1, but not the kinase-inactive Snf1<sup>T210A</sup> mutant, was able to phosphorylate this Sch9 fragment, and mutation of Ser<sup>288</sup> to alanine in the Sch9 fragment significantly reduced the respective phosphorylation level, indicating that this residue is likely the primary Snf1 target in the N-terminal part of Sch9 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). To further study the dynamics of Ser<sup>288</sup> phosphorylation in vivo, we raised antibodies that specifically recognize phosphorylated Ser<sup>288</sup> in Sch9 (Sch9-pSer<sup>288</sup>). Using these antibodies, we observed that the Sch9-pSer<sup>288</sup> levels were barely detectable in <italic>snf1<sup>as</sup></italic> cells growing exponentially on 2% glucose, but then rapidly and strongly increased in a Snf1-dependent manner following glucose starvation in DMSO-treated cells but not in 2NM-PP1 treated, Snf1-inhibited cells (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; upper panels, left side). In addition, the Sch9-pSer<sup>288</sup> levels were quite elevated in cells growing exponentially on very low glucose levels (i.e. 0.05%), but rapidly declined in cells where Snf1<sup>as</sup> was inactivated by 2NM-PP1 treatment (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; upper panels, right side). As expected, in control experiments performed with strains expressing Sch9<sup>S288A</sup> or Sch9<sup>S288E</sup> mutant versions, no Sch9-pSer<sup>288</sup> signal was detected (middle and lower panels). Together with our finding that the Snf1 complex was also able to bind the N-terminal Sch9 fragment in microscale thermophoresis assays (<xref ref-type="fig" rid="fig5">Figure 5E</xref>), our data therefore indicate that Ser<sup>288</sup> in Sch9 is a bona fide Snf1 target residue.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Snf1 phosphorylates Sch9-Ser<sup>288</sup> to antagonize Sch9-Thr<sup>737</sup> phosphorylation.</title><p>(<bold>A</bold>) Schematic representation of the structure of Sch9 with the C2 domain, the kinase domain including the T-loop, the turn motif, and the hydrophobic motif (HM). The position of the potential Snf1 target residue (<italic>i.e</italic>. phosphorylated [P] Ser<sup>288</sup>) and one of the 5 C-terminal TORC1 target residues (<xref ref-type="bibr" rid="bib117">Urban et al., 2007</xref>; i.e. phosphorylated [P] Thr<sup>737</sup> in the HM motif that is used to probe TORC1 activity here) are indicated. (<bold>B</bold>) Phosphoproteomic analyses identify Sch9-Ser<sup>288</sup> as a potential Snf1 target. Mean phosphorylation levels of Sch9-Ser<sup>288</sup> in untreated (DMSO) and 2NM-PP1-treated <italic>snf1<sup>as</sup></italic> cells, grown exponentially (Exp) and limited for glucose (0.05% Glc) for the times indicated, were extracted from the SILAC experiment (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>) and normalized to the ones in exponentially growing cells (set to 1.0; n=3; + SD; unpaired Student’s t-test, *FDR ≤0.05). (<bold>C</bold>) Snf1 phosphorylates Ser<sup>288</sup> in Sch9 in vitro. Snf1 (WT) and kinase-inactive Snf1<sup>T210A</sup> (TA) were purified from yeast and used in protein kinase assays with [γ-<sup>32</sup>P]-ATP and the N-terminal fragment of Sch9 (encompassing the N-terminal 394 amino acids; Sch9<sup>1-394</sup>) as substrate (WT). In parallel protein kinase assays, we also used the respective Sch9<sup>1-394</sup> fragment harboring the Ser<sup>288</sup>-to-Ala mutation as substrate (S288A). Substrate phosphorylation was detected by autoradiography (<sup>32</sup>P, lower panel) and Sypro Ruby (SyR) staining is shown as loading control for the Snf1 variants (upper panel) and the Sch9 fragments (panel in the middle). The mean phosphorylation of the Sch9<sup>S288A</sup> mutant fragment by wild-type Snf1 (i.e. <sup>32</sup>P signal/Sypro Ruby [SyR] substrate input level; nd, not detected) was assessed relative to the one of the Sch9<sup>WT</sup> fragment (set to 1.0, n=3; ± SEM; unpaired Student’s t-test, **p≤0.05; nd, not detected). (<bold>D</bold>) Snf1 controls Sch9-Ser<sup>288</sup> phosphorylation in vivo. Cells (<italic>i.e. snf1<sup>as</sup></italic>, <italic>snf1<sup>as</sup> sch9<sup>S288A</sup></italic>, and <italic>snf1<sup>as</sup> sch9<sup>S288E</sup></italic>) were grown exponentially on 2% glucose (Exp) and then starved for glucose (-C) in the absence (DMSO) or presence of 2NM-PP1 for the times indicated (panels on the left). In parallel, cells were grown exponentially (Exp) on low glucose media (0.05%; panels on the right) and then treated with vehicle (DMSO) or 2-NMPP1 for the times indicated. The levels of Ser<sup>288</sup> phosphorylation in Sch9 (Sch9-pSer<sup>288</sup>) and total levels of Sch9 were assayed by immunoblot analyses using anti-Sch9-pSer<sup>288</sup> and anti-Sch9 antibodies, respectively (n=3). (<bold>E</bold>) Snf1 binds Sch9. The binding affinity between Sch9<sup>1-394</sup> (purified from yeast) titrated against the Snf1 complex (also purified from yeast and containing the C-terminally GFP-tagged Snf4 γ-subunit) was assessed by microscale thermophoresis. The dissociation constant (K<sub>D</sub>; 95% profile likelihood = 3.2–19.1 nM; n=3; ± SEM) was calculated using a nonlinear asymmetric sigmoidal regression. (<bold>F, G</bold>) The phosphomimetic Sch9<sup>S288E</sup> allele compromises proper phosphorylation of the C-terminal Thr<sup>737</sup> residue in Sch9. <italic>snf1<sup>as</sup></italic>, <italic>snf1<sup>as</sup> sch9<sup>S288A</sup></italic> (<italic>sch9<sup>SA</sup></italic>), and <italic>snf1<sup>as</sup> sch9<sup>S288E</sup></italic> (<italic>sch9<sup>SE</sup></italic>) cells were grown exponentially (Exp) and then starved for 10 min for glucose (-C) in the absence (-; DMSO) or the presence (+) of 2NM-PP1. Immunoblot analyses of Sch9-pThr<sup>737</sup>, Sch9, Snf1-pThr<sup>210</sup>, and Snf1 were carried out as in <xref ref-type="fig" rid="fig1">Figure 1A</xref> (<bold>F</bold>). The mean relative TORC1 activities in the three strains were quantified as in <xref ref-type="fig" rid="fig1">Figure 1B</xref> and normalized to the values in exponentially growing <italic>snf1<sup>as</sup></italic> cells (set to 1.0; n=6; + SEM; unpaired Student’s t-test, *p≤0.05, **p≤0.005) (<bold>G</bold>). The online version of this article includes the following source data for <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>, data for the graph shown in (<bold>B and E</bold>) and quantifications of the blots in (<bold>C</bold>) and for the graph shown in (<bold>G</bold>); <xref ref-type="supplementary-material" rid="fig5sdata2">Figure 5—source data 2</xref>, uncropped blots, gels and autoradiographies shown in (<bold>C, D and F</bold>); <xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5—source data 3</xref>, raw blots, gels and autoradiographies shown in (<bold>C, D and F</bold>).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Data for the graph shown in B and E and quantifications of the blots in C and for the graph shown in G.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84319-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Uncropped blots, gels and autoradiographies shown in C, D and F.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84319-fig5-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Raw blots, gels and autoradiographies shown in C, D and F.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig5-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Snf1 in vitro kinase assays.</title><p>The assays were performed as in <xref ref-type="fig" rid="fig5">Figure 5C</xref>, except for the use of cold ATP and the inclusion of a full-length kinase-dead Sch9 variant (Sch9<sup>KD</sup>: KD) as substrate. In addition, phosphorylation of Sch9-Ser<sup>288</sup> and the levels of Sch9<sup>KD</sup> or Sch9<sup>1-394</sup> variants were assayed by immunoblot analyses using specific anti-Sch9-pSer<sup>288</sup> (left blot) and anti-Sch9 (right blot) antibodies, respectively (n=2). Nomenclature: wild-type Snf1 complex: WT; kinase-inactive Snf1<sup>T210A</sup> complex: TA; N-terminal wild-type fragment of Sch9 encompassing the N-terminal 394 amino acids (Sch9<sup>1-394</sup>): WT; and Sch9<sup>1-394</sup> harboring the Ser<sup>288</sup>-to-Ala mutation: SA. The online version of this article includes the following source data for <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>, uncropped blots; <xref ref-type="supplementary-material" rid="fig5s1sdata2">Figure 5—figure supplement 1—source data 2</xref>, raw blots. .</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Uncropped blots.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84319-fig5-figsupp1-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Raw blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig5-figsupp1-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig5-figsupp1-v2.tif"/></fig></fig-group><p>To address the physiological role of Ser<sup>288</sup> phosphorylation in Sch9, we next studied the relative TORC1 activity upon short-term glucose starvation in 2NM-PP1-treated and -untreated <italic>snf1<sup>as</sup></italic> strains that expressed either wild-type Sch9, the phosphomutant Sch9<sup>S288A</sup>, or the phosphomimetic Sch9<sup>S288E</sup> using Sch9-pThr<sup>737</sup> levels as a proxy. Interestingly, expression of Sch9<sup>S288E</sup>, but not expression of wild-type Sch9 or Sch9<sup>S288A</sup>, slightly but significantly suppressed the unscheduled reactivation of TORC1 in 2NM-PP1-treated Snf1<sup>as</sup>-inhibited glucose-starved cells (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>). Thus, our data suggest that Snf1-mediated phosphorylation of Ser<sup>288</sup> negatively impacts on the capacity of TORC1 to phosphorylate the C-terminal Thr<sup>737</sup> in Sch9.</p></sec><sec id="s2-5"><title>Physiological effects of Sch9<sup>S288E</sup> and Pib2<sup>S268E,S309E</sup> are additive</title><p>Our data so far indicated that Snf1 controls TORC1 signaling both upstream (Pib2) and downstream (Sch9) of TORC1. To address the question of whether these effects are additive concerning the TORC1-controlled phosphorylation of Thr<sup>737</sup> in Sch9, we studied <italic>snf1<sup>as</sup></italic> strains in which the phosphomutant and phosphomimetic variants of Sch9 and Pib2 were expressed separately or combined. In line with our data above, the separate expression of Sch9<sup>S288E</sup> in Snf1<sup>as</sup>-inhibited (2NM-PP1-treated), glucose-starved cells only weakly suppressed the unscheduled reactivation of TORC1 (i.e. relative Sch9-Thr<sup>737</sup> phosphorylation), while this effect was already strong in case of the separate expression of Pib2<sup>S268E,S309E</sup> and even stronger when the expression of Sch9<sup>S288E</sup> and Pib2<sup>S268E,S309E</sup> were combined (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). In contrast, the separate and combined expression of Sch9<sup>S288A</sup> and Pib2<sup>S268A,S309A</sup> showed, as predicted, no significant effect in the same experiment. Unexpectedly, however, the latter combination did not result in transient reactivation of TORC1, like we observed in glucose-starved, Snf1-compromised cells. This may be explained if TORC1 reactivation would rely on specific biophysical properties of the non-phosphorylated serine residues within Sch9 and Pib2 that are not mimicked by respective serine-to-alanine substitutions. Alternatively, Snf1 may employ additional parallel mechanisms (perhaps through phosphorylation of Tco89, Kog1, and/or other factors; see above) to prevent TORC1 reactivation even when Pib2 and Sch9 cannot be appropriately phosphorylated. While such models warrant future studies, our current data still suggest that Snf1-mediated phosphorylation of Pib2 and Sch9 may be both additive and together sufficient to appropriately maintain TORC1 inactive in glucose-starved cells. Corroborating this conclusion, we found the combined expression of Pib2<sup>S268E,S309E</sup> and Sch9<sup>S288E</sup>, but not their individual expression, nor individual or combined expression of Pib2<sup>S268A,S309A</sup> and Sch9<sup>S288A</sup>, to significantly reduce the relative Sch9-Thr<sup>737</sup> phosphorylation when cells were grown exponentially on low-nitrogen-containing media where TORC1 activity is intrinsically low and Snf1 activity somewhat elevated (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). In line with these data, the <italic>snf1<sup>as</sup> pib2<sup>SESE</sup> sch9<sup>SE</sup></italic> strain also exhibited a slightly higher doubling time than the <italic>snf1<sup>as</sup></italic> strain that was statistically significant on both low-nitrogen-containing media (i.e. 3.28±0.04 h versus 3.06±0.03 h, respectively; n=3; ± SEM; p&lt;0.05) and standard synthetic complete media (i.e. 1.44±0.02 h versus 1.38±0.01 h, respectively; n=3; ± SEM; p&lt;0.05). Finally, cells that combined the expression of Pib2<sup>S268E,S309E</sup> and Sch9<sup>S288E</sup> were also more sensitive to sub-inhibitory concentrations of rapamycin than cells expressing only one of these alleles (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Thus, Snf1-mediated fine-tuning of TORC1 activity relies on the proper phosphorylation of both Pib2 and Sch9.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Physiological effects of Sch9<sup>S288E</sup> and Pib2<sup>S268E,S309E</sup> are additive.</title><p>(<bold>A, B</bold>) Exponentially growing (E) <italic>snf1<sup>as</sup></italic> cells expressing the indicated combinations of wild type Pib2 (Pib2 variant: WT), Pib2<sup>S268A,S309A</sup> (Pib2 variant: SASA), and Pib2<sup>S268E,S309E</sup> (Pib2 variant: SESE) and wild type Sch9 (Sch9 variant: WT), Sch9<sup>288A</sup> (Sch9 variant: SA), and Sch9<sup>S288E</sup> (Sch9 variant: SE) were starved for glucose (10 min; -C) in the absence (-; DMSO; upper panels) and presence of 2NM-PP1 (+; lower panels). Immunoblot analyses were performed as in <xref ref-type="fig" rid="fig1">Figure 1A</xref> and the mean relative TORC1 activities (i.e. Sch9-pThr<sup>737</sup>/Sch9) were quantified, normalized relative to exponentially growing <italic>snf1<sup>as</sup></italic> cells (set to 1.0), and shown in the bar diagram in (<bold>B</bold>) (n=4; + SEM; unpaired Student’s t-test, *p≤0.05, **p≤0.005, ***p≤0.0005). (<bold>C</bold>) Growth on media containing low nitrogen levels activates Snf1-Thr<sup>210</sup> phosphorylation and decreases TORC1 activity. WT cells were grown exponentially on SC or low nitrogen medium and assayed for their mean relative TORC1 activities (Sch9-pThr<sup>737</sup>/Sch9) and Snf1-Thr<sup>210</sup> phosphorylation levels (Snf1-pThr<sup>210</sup>/Snf1), each normalized to the values of cells grown on SC (set to 1.0; n=10; ± SEM). In unpaired Student’s tests, both values in cells growing on low nitrogen medium were significantly different form the ones growing on SC (**p≤0.005, ****p≤0.005). (<bold>D, E</bold>) Combined expression of Sch9<sup>S288E</sup> and Pib2<sup>S268E,S309E</sup> causes reduced Sch9-Thr<sup>737</sup> phosphorylation (<bold>D</bold>) and enhanced rapamycin sensitivity (<bold>E</bold>). In (<bold>D</bold>), indicated strains were grown exponentially on low nitrogen medium and assayed for their mean TORC1 activities as in (<bold>C</bold>), which were normalized to the value of WT cells (set to 1.0; n=4; ± SEM; unpaired Student’s t-test, **p≤0.005). In (<bold>E</bold>), cells with the indicated genotypes were grown exponentially in SD, then 10-fold serially diluted, spotted on control plates (SD) or 2.5 nM rapamycin-containing plates, and grown for 3 days at 30 °C (n=4). The online version of this article includes the following source data for <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>, quantifications of the blots in (<bold>C and D</bold>) and for graph shown in (<bold>B</bold>); <xref ref-type="supplementary-material" rid="fig6sdata2">Figure 6—source data 2</xref>, uncropped blots shown in (<bold>A, C and D</bold>); uncropped dropspots shown in (<bold>E</bold>); <xref ref-type="supplementary-material" rid="fig6sdata3">Figure 6—source data 3</xref>, raw blots shown in (<bold>A, C and D</bold>); raw dropspots shown in (<bold>E</bold>).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Quantifications of the blots in C and D and for graph shown in B.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-84319-fig6-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Uncropped blots shown in A, C and D; uncropped dropspots shown in E.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-84319-fig6-data2-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Raw blots shown in A and C.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig6-data3-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Raw blots shown in D; raw dropspots shown in E.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84319-fig6-data4-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84319-fig6-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Snf1/AMPK and TORC1 are conserved central kinase modules of two opposing signaling pathways that control cell growth and metabolism in response to the availability of nutrients and energy. Accordingly, energy depletion activates Snf1/AMPK, which helps to maintain energy homeostasis by favoring catabolic and inhibiting anabolic processes that generate and consume ATP, respectively (<xref ref-type="bibr" rid="bib39">Hardie et al., 2012</xref>). In contrast, intracellular nutrients and high energy levels activate TORC1, which favors anabolic processes such as lipid, nucleotide, and protein synthesis and inhibits the catabolic autophagic recycling of macromolecules (<xref ref-type="bibr" rid="bib1">Albert and Hall, 2015</xref>; <xref ref-type="bibr" rid="bib35">González and Hall, 2017</xref>; <xref ref-type="bibr" rid="bib57">Laplante and Sabatini, 2012</xref>; <xref ref-type="bibr" rid="bib61">Liu and Sabatini, 2020</xref>). Given the reciprocal cellular roles of Snf1/AMPK and TORC1, it is not surprising that their signaling pathways are wired to each other at different levels to coordinate the establishment of cellular homeostasis. TORC1, for instance, phosphorylates and thereby inhibits the catalytic subunit of AMPK in both mammals and the fission yeast <italic>Schizosaccharomyces pombe</italic> (<xref ref-type="bibr" rid="bib60">Ling et al., 2020</xref>). Conversely, AMPK inhibits mTORC1 through phosphorylation of TSC2 and Raptor (<xref ref-type="bibr" rid="bib38">Gwinn et al., 2008</xref>; <xref ref-type="bibr" rid="bib49">Inoki et al., 2003b</xref>), while Snf1 contributes to TORC1-body formation through phosphorylation of Kog1, although this does not seem to be required for rapid TORC1 inactivation, nor for maintaining TORC1 inactive following acute glucose starvation (<xref ref-type="bibr" rid="bib47">Hughes Hallett et al., 2015</xref>; <xref ref-type="bibr" rid="bib106">Sullivan et al., 2019</xref>). In this context, the heterodimeric Gtr1-Gtr2 Rag GTPase complex has been mechanistically linked to the rapid glucose-starvation induced inactivation of TORC1 and its assembly into oligomeric structures coined TOROIDs (TORC1 organized in inhibited domains) (<xref ref-type="bibr" rid="bib89">Prouteau et al., 2017</xref>), but these processes occur independently of Snf1 and rely on still elusive mechanisms that link glucose signals to the nucleotide-loading state of the Rag GTPases. Despite these findings, Snf1 may be more intimately linked to TORC1 than current knowledge suggests, because both our current and previous proteomics approaches identified several additional potential Snf1 target residues within TORC1 and some of its upstream regulators (<xref ref-type="bibr" rid="bib13">Braun et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Kanshin et al., 2017</xref>). Here, we followed up on one of these leads, that is Pib2, and demonstrated that the Snf1-mediated phosphorylation of Pib2 is critical to maintain TORC1 inactive during the early phase of acute glucose starvation. Thus, our data extend the function of Pib2 to a hub that integrates both glutamine, as reported earlier (<xref ref-type="bibr" rid="bib108">Tanigawa and Maeda, 2017</xref>; <xref ref-type="bibr" rid="bib109">Tanigawa et al., 2021</xref>; <xref ref-type="bibr" rid="bib116">Ukai et al., 2018</xref>), and glucose signals to control TORC1. Our current data favor a model according to which Snf1-mediated phosphorylation of the Kog1-binding domain in Pib2 weakens its affinity to Kog1 and thereby reduces the TORC1-activating influence of Pib2 that is mediated by the C-terminal TORC1-activating (CAD) domain via a mechanism that is still largely elusive. Interestingly, Pib2 has also been involved in the formation of TORC1-bodies, which seem not to be required for TORC1 inactivation per se but rather serve to increase the threshold for TORC1 reactivation after long-term glucose starvation (<xref ref-type="bibr" rid="bib106">Sullivan et al., 2019</xref>). The latter process is primarily driven by phosphorylation of Kog1 and, albeit dependent on Pib2, may also require loosening of the Kog1-Pib2 association, because deletion of the N-terminal TORC1-inhibitory domain (NID) in Pib2 has been found to induce TORC1-body formation (<xref ref-type="bibr" rid="bib106">Sullivan et al., 2019</xref>). Here too, the mechanistic details remain to be deciphered and will likely require detailed structural information on the interactions between Pib2, Kog1, and the EGOC that also plays a role in TORC1-body formation (<xref ref-type="bibr" rid="bib106">Sullivan et al., 2019</xref>). Curiously, human phafin/LAPF, which is structurally most closely related to Pib2 and with which it shares the FYVE and CAD domains (<xref ref-type="bibr" rid="bib55">Kim and Cunningham, 2015</xref>), also regulates mTORC1-controlled processes, but it remains currently unknown whether these effects are executed through regulation of mTORC1 (<xref ref-type="bibr" rid="bib41">Hatakeyama, 2021</xref>).</p><p>The activities of the Snf1 and TORC1 pathways are also wired to each other through a set of directly or indirectly controlled common effectors that, given the opposite roles of Snf1 and TORC1 in cell metabolism, are generally inversely regulated by these pathways (<xref ref-type="bibr" rid="bib26">De Virgilio, 2012</xref>). For instance, Snf1 and TORC1 converge on the transcription factor Gln3 and the eukaryotic translation initiation factor 2α (eIF2α) to oppositely regulate their function (<xref ref-type="bibr" rid="bib8">Beck and Hall, 1999</xref>; <xref ref-type="bibr" rid="bib9">Bertram et al., 2002</xref>; <xref ref-type="bibr" rid="bib20">Cherkasova et al., 2010</xref>; <xref ref-type="bibr" rid="bib19">Cherkasova and Hinnebusch, 2003</xref>). Interestingly, Snf1 and TORC1 have already previously been reported to directly converge on different residues within Sch9 (<xref ref-type="bibr" rid="bib65">Lu et al., 2011</xref>), a key controller of protein synthesis and aging in yeast (<xref ref-type="bibr" rid="bib63">Loewith and Hall, 2011</xref>). Accordingly, both kinases phosphorylate Sch9, but, while the TORC1 target residues in Sch9 have been functionally well-defined and located in the C-terminus of Sch9 (<xref ref-type="bibr" rid="bib117">Urban et al., 2007</xref>), the respective Snf1 target residue(s) remained unidentified (<xref ref-type="bibr" rid="bib65">Lu et al., 2011</xref>). Here, we show that Snf1 phosphorylates Ser<sup>288</sup> in Sch9, which is not only supported by our current and previous phosphoproteomic approaches (<xref ref-type="bibr" rid="bib13">Braun et al., 2014</xref>), but also by our extended biochemical in vitro and in vivo studies of wild-type and Sch9<sup>S288A</sup> alleles. In line with the opposite conceptual roles of Snf1 and TORC1 within cells, our physiological experiments posit a model in which Snf1-mediated phosphorylation of Ser<sup>288</sup> in Sch9 antagonizes the TORC1-mediated phosphorylation (at Thr<sup>737</sup>) and hence activation of Sch9. Notably, such a model also provides an elegant explanation for the reciprocal role of Snf1 and Sch9 in controlling chronological life span (<xref ref-type="bibr" rid="bib67">Maqani et al., 2018</xref>; <xref ref-type="bibr" rid="bib121">Wei et al., 2008</xref>; <xref ref-type="bibr" rid="bib122">Wierman et al., 2017</xref>), although it is difficult to reconcile with the idea that Snf1 activates Sch9 (in parallel to TORC1) to inhibit replicative lifespan (<xref ref-type="bibr" rid="bib65">Lu et al., 2011</xref>). The latter assumption, however, appears to depend in part on the phosphorylation of a threonine(s) in Sch9, specifically in cells lacking the regulatory Snf1 subunit Sip2, and may therefore not be related to the Sch9-Ser<sup>288</sup> phosphorylation studied here. Of note, the question of how Ser<sup>288</sup> phosphorylation restrains TORC1-mediated phosphorylation of Sch9-Thr<sup>737</sup> also warrants further experimental efforts. The Ser<sup>288</sup> residue lies within the C2 domain that has been suggested to mediate the vacuolar recruitment of Sch9 (<xref ref-type="bibr" rid="bib51">Jin et al., 2014</xref>). However, recent studies have elaborated that the membrane-localization of Sch9 is primarily defined by its N-terminal 184 amino acids, but not the C2 domain (<xref ref-type="bibr" rid="bib18">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="bib76">Novarina et al., 2021</xref>). We therefore assume that the phosphorylation of Ser<sup>288</sup> within the C2 domain, rather than controlling the subcellular localization, may either favor the recruitment of a pThr<sup>737</sup>-targeting phosphatase to Sch9 or interfere with appropriate TORC1 docking. The latter could for instance be achieved if the phosphorylated C2 domain would act as an auto-inhibitory domain that folds back to the C-terminal part of Sch9 to impose specific conformational constraints. Intriguingly, a similar regulatory mechanism has been suggested for the protein kinase Ypk1, a TORC2 target that is very closely related to Sch9 (<xref ref-type="bibr" rid="bib111">Thorner, 2022</xref>). In this case, structural predictions suggested that a critical aspartate (D242) located in a N-terminal C2-like domain is packed tightly against the upper lobe of the kinase domain in Ypk1 to favor its inactive state (<xref ref-type="bibr" rid="bib118">van Dam et al., 2011</xref>). For Sch9, as for Pib2, the resolution of these issues will likely require more detailed structural information on Sch9 that is currently not available.</p><p>In this study, we focused on the mechanisms through which Snf1 regulates TORC1 during the early phase of acute glucose starvation. Our phosphoproteome data, however, indicate that Snf1 may also control TORC1 through processes that are relevant during later phases of prolonged glucose starvation. For instance, we identified the lipid kinase Fab1, which generates phosphatidylinositol-3,5-bisphosphate (PI(3,5)P<sub>2</sub>) from PI3P, as a potential Snf1 target (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Fab1 is not only a TORC1 effector, but it also defines the activity and subcellular distribution (between vacuolar membranes and signaling endosomes) of TORC1 (<xref ref-type="bibr" rid="bib18">Chen et al., 2021</xref>). Snf1 may therefore modulate the feedback control loop between Fab1 and TORC1 in response to glucose limitation. This function is likely executed by Snf1 complexes containing the β-subunit Sip1, which, in addition to being potentially feedback-controlled by Snf1, tethers Snf1 complexes to vacuolar membranes in response to carbon stress (<xref ref-type="bibr" rid="bib42">Hedbacker et al., 2004</xref>). We also identified Snf1-regulated phospho-residues in Apl6, a subunit of the adaptor protein 3 (AP-3) complex that functions in cargo-selective protein transport from the TGN to the vacuole (<xref ref-type="bibr" rid="bib22">Cowles et al., 1997</xref>). In this case, Snf1 may control the flux of Ego1 towards (and hence assembly of the TORC1-regulatory EGOC at) vacuolar membranes, which requires proper AP-3 function (<xref ref-type="bibr" rid="bib40">Hatakeyama et al., 2019</xref>). Our mass spectrometry approaches further highlighted several phospho-residues in α-arrestins including Aly2, Bul1, and Bul2 that appeared to be regulated by Snf1. These arrestins drive Rsp5-mediated ubiquitination of specific nutrient transporters such as the amino acid permeases Gap1, Dip5, and others to orchestrate their endocytosis in response to nutrients (<xref ref-type="bibr" rid="bib52">Kahlhofer et al., 2021</xref>; <xref ref-type="bibr" rid="bib129">Zbieralski and Wawrzycka, 2022</xref>). Because amino acid permeases control TORC1 either via their role in distributing amino acids across cellular membrane compartments or through their proposed role as transceptors (<xref ref-type="bibr" rid="bib70">Melick and Jewell, 2020</xref>; <xref ref-type="bibr" rid="bib124">Wolfson and Sabatini, 2017</xref>; <xref ref-type="bibr" rid="bib130">Zheng et al., 2016</xref>), it is conceivable that Snf1 also controls TORC1 indirectly via phosphorylation of α-arrestins. In a similar vein, Snf1 may also reduce ammonium uptake by impinging on the Npr1-regulated Par32, which inhibits the ammonium transporters Mep1 and Mep3 and thereby indirectly reduces TORC1 activity (<xref ref-type="bibr" rid="bib11">Boeckstaens et al., 2015</xref>; <xref ref-type="bibr" rid="bib120">Varlakhanova et al., 2018</xref>). Finally, two protein kinases, namely Ptk2 and Hkr1, which activate the plasma membrane H<sup>+</sup>-ATPase Pma1 in response to glucose (<xref ref-type="bibr" rid="bib31">Eraso et al., 2006</xref>; <xref ref-type="bibr" rid="bib37">Goossens et al., 2000</xref>), were also among the presumed Snf1 targets in our data set (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Through Ptk2 and Hkr1, Snf1 may conceivably adjust TORC1 activation that is related to Pma1 and H<sup>+</sup>-coupled nutrient uptake (<xref ref-type="bibr" rid="bib94">Saliba et al., 2018</xref>). In sum, our proteomics study provides a wealth of new leads for future studies on how Snf1 may be wired to TORC1 to ensure cellular homeostasis under long-term glucose limitation.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Yeast strains, plasmids, and growth conditions</title><p><italic>Saccharomyces cerevisiae</italic> strains and plasmids are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>. Point mutations were introduced in the genome by CRISPR-Cas9, as described (<xref ref-type="bibr" rid="bib33">Generoso et al., 2016</xref>), while gene deletion and tagging were performed using the pFA6a system-based PCR-toolbox (<xref ref-type="bibr" rid="bib50">Janke et al., 2004</xref>). The oligos used to generate the CRISPR-Cas9 plasmids are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref>. Plasmids were created as described earlier (<xref ref-type="bibr" rid="bib33">Generoso et al., 2016</xref>). Strains were rendered prototrophic, unless stated otherwise, by transforming them with the empty centromeric plasmids listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>. In order to maintain the plasmids, cells were pregrown in a synthetic dropout (SD; 0.17% yeast nitrogen base, 0.5% ammonium sulfate [AS], 0.2% dropout mix [USBiological], and 2% glucose) medium. Then, synthetic complete (SC; SD with all amino acids) medium was used for the dilution of the cells the following day. The same procedure was adopted for experiments where cells were grown in media containing low glucose (i.e. 0.05% instead of 2% glucose) or low nitrogen (with a reduced amount of AS [0.0625%] and devoid of amino acids). Starvation experiments were performed by cell filtration and transfer to carbon starvation medium (SC without glucose), nitrogen starvation medium (2% glucose, 0.17% yeast nitrogen base) or nitrogen and carbon starvation medium (0.17% yeast nitrogen base), for the times indicated. For re-addition experiments, 2% final glucose and/or 3.3 mM glutamine was/were added to the culture. When indicated, 10 µM 2NM-PP1 dissolved in DMSO was added to the culture. As a control, the same volume of DMSO was added. Strains and plasmids are available upon request. Cell growth was monitored by measuring the concentration (OD<sub>600nm</sub>/mL) with a spectrophotometer.</p></sec><sec id="s4-2"><title>Growth tests on plates</title><p>Cells were pregrown over-day in SD or SC until OD<sub>600nm</sub> above 1.0. Cells were washed two times with water and starting from the concentration of 1.0 OD<sub>600nm</sub>/mL, 10-fold serial dilutions were prepared in water. Cells were spotted on SD or SC plates with or without rapamycin, at the indicated concentrations, and further grown for 3 days at 30 °C.</p></sec><sec id="s4-3"><title>SILAC conditions and cell lysis</title><p>Yeast strains were grown in SC medium containing either non-labeled or labeled lysine and arginine variants (‘medium-heavy’ L-arginine-<sup>13</sup>C<sub>6</sub> (Arg6) and L-lysine-<sup>2</sup>H<sub>4</sub> (Lys4), or ‘heavy’ L-arginine-<sup>13</sup>C<sub>6</sub>-<sup>15</sup>N<sub>4</sub> (Arg10) and L-lysine-<sup>13</sup>C<sub>6</sub>-<sup>15</sup>N<sub>2</sub> (Lys8) amino acids (Sigma-Aldrich)), until reaching an OD<sub>600nm</sub> of approximatively 1.0. Then, cultures grown in the presence of ‘medium-heavy’ and ‘heavy’ arginine and lysine were filtered and resuspended in carbon starvation medium for 5 and 15 min, respectively, in the presence of the vehicle (DMSO) or 2NM-PP1. All cultures were ultimately collected by filtration. The nitrocellulose filter was dipped in tubes containing 40 mL of the cell culture medium plus TCA, 6% final concentration. Cells were pelleted and washed with 40 mL acetone and subsequently dried overnight in a freeze-dryer (ZIRBUS). Dried differentially labeled cells (30 mg) of each sample were mixed. Cells were lysed in 50 mL tubes with 6 mL urea buffer (8 M urea, 50 mM Tris HCl pH 8.0) and acid-washed glass beads using a Precellys machine (6x30 s, with 60 s pause after each cycle). Debris were pelleted and the supernatants containing cellular proteins were collected, followed by MS sample preparation.</p></sec><sec id="s4-4"><title>On beads in vitro kinase assay (OBIKA)</title><p>Cell pellets were obtained by five different cultures of exponentially growing <italic>snf1<sup>as</sup></italic> cells. Cells were pre-grown overnight in 5% glucose YP (yeast extract-peptone) and the following day, they were diluted at the concentration of 0.2 OD<sub>600nm</sub>/mL in 2 L 5% glucose YP (yeast extract-peptone). Cells were grown until late exponential phase, when they were treated with 10 µM 1NM-PP1 for 20 min. Cells were then collected by filtration, frozen in liquid nitrogen, and cryogenically disrupted by using a Precellys homogenizer in 10 mL of primary amine-free lysis buffer (50 mM HEPES pH 7.5, 1% NP-40, 150 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0 and Roche complete protease inhibitor EDTA-free) and acid-washed glass beads using a Precellys machine (6x30 s, with 60 s pause after each cycle). Lysates were collected by centrifugation at 4000 rpm at 4 °C. The lysates were dialyzed using dialysis buffer (50 mM HEPES pH 7.5, 0.1% NP-40, 150 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0, and 1 mM PMSF) and a molecular-porous membrane tubing (14 kDa, Sigma-Aldrich) to remove primary amine containing metabolites. After 2 h at 4 °C, the buffer was refreshed for overnight dialysis. N-hydroxy-succinimide (NHS) -activated Sepharose beads (5 mL) were washed three times with 10 mL of ice-cold 1 mM HCl and two times with 10 mL of lysis buffer before incubating with 60 mg protein to saturate the beads. The coupling was performed on a rotating mixer at 4 °C overnight. Next, the beads were spun down to remove the supernatant. Beads were then washed three times with 10 mL of phosphatase buffer (50 mM HEPES, 100 mM NaCl, 0.1% NP-40). Phosphatase buffer (1 mL) containing 5’000–10’000 units of lambda phosphatase with 1 mM MnCl<sub>2</sub> was added and incubated for 4 h at room temperature or overnight at 4 °C on a rotating mixer to dephosphorylate endogenous proteins. Beads were washed two times with 10 mL of kinase buffer (50 mM Tris-HCl pH 7.6, 10 mM MgCl<sub>2</sub>, 150 mM NaCl, and 1 x PhosSTOP). Endogenous kinases bound to beads were inhibited by incubation with 1 mM FSBA in 1 mL of kinase buffer at RT on the rotor for 2 h. In addition, staurosporine was added to a final concentration of 100 μM to inhibit the remaining active kinases for 1 h. The beads were washed three times with 10 mL of kinase buffer to remove non-bound kinase inhibitors. The supernatant was removed completely by gel loading tips. Kinase buffer was added to a volume of 860 μL for both kinase inactive and wild-type Snf1 samples. Subsequently, 100 μl of 10 mM ATP, 10 μL of 100 mM DTT, and 30 μl of purified kinase variants were added into each tube. Kinase assays were performed on a rotor at 30 °C for 4 h. Finally, reactions were quenched by snap freezing in liquid nitrogen and samples were lyophilized overnight. Urea buffer (250 μL) was added to the dry beads, followed by MS sample preparation (<xref ref-type="bibr" rid="bib46">Hu et al., 2021</xref>).</p></sec><sec id="s4-5"><title>MS sample preparation</title><p>For in vivo phosphoproteome and OBIKA samples, lysates or proteins on beads were reduced with 1 mM DTT, alkylated with 5 mM iodoacetamide, and digested with endoproteinase Lys-C for 4 h. The concentration of urea was diluted to 1 M before overnight trypsin digestion. The peptides were purified and fractionated as described previously (<xref ref-type="bibr" rid="bib45">Hu et al., 2019</xref>). Briefly, peptides were purified by SPE using HR-X columns in combination with C18 cartridges. The purified peptides were frozen, lyophilized, and fractionated by HpH reversed-phase chromatography (<xref ref-type="bibr" rid="bib7">Batth et al., 2014</xref>). A total of 96 fractions were mixed with an interval of 12 to yield 8 final fractions. The peptides were acidified, frozen in liquid nitrogen, and lyophilized before phosphopeptide enrichment.</p><p>For manual phosphopeptide enrichment, samples were incubated with 2 mg TiO<sub>2</sub> slurry, which was pre-incubated with 300 mg/mL lactic acid in 80% acetonitrile/1% trifluoroacetic acid (TFA) before enrichment for 30 min at room temperature (<xref ref-type="bibr" rid="bib128">Zarei et al., 2016</xref>). For peptide elution, TiO<sub>2</sub> beads were transferred to 200 μL pipette tips, which were blocked by C8 discs. Tips were sequentially washed with 200 μL of 10% acetonitrile/1% TFA, twice with 200 μL of 80% acetonitrile/1% TFA, and 100 μL of LC-MS grade water. Phosphopeptides were eluted into single tubes with 50 μL of 1.25% ammonia in 20% acetonitrile and 50 μL of 1.25% ammonia in 80% acetonitrile. Eluates were acidified with 5 μL of formic acid. Samples were concentrated by vacuum concentration and resuspended in 20 μL of 0.1% formic acid for LC-MS/MS analysis. The tip flow-through was desalted by STAGE tips for non-phosphopeptide analysis.</p><p>Automated phosphopeptide enrichment was performed on an Automated Liquid Handling Platform (Bravo, Agilent) (<xref ref-type="bibr" rid="bib86">Post et al., 2017</xref>). The Fe (III)-NTA cartridges (5 µL) were primed with 0.1% TFA in acetonitrile and equilibrated with 0.1% TFA in 80% acetonitrile (equilibration/washing buffer). Peptides were resuspended in 200 µL of equilibration buffer and loaded on the cartridges with a flow rate of 5 µL/min. Cartridges were washed twice with 200 µL of washing buffer with a flow rate of 10 µL/min. Phosphopeptides were eluted with 100 μL of 1% ammonia in 80% acetonitrile with a flow rate of 5 µL/min. Eluates were acidified with 5 μL of formic acid. Samples were concentrated by lyophilizer and resuspended in 20 μL of 0.1% formic acid for LC-MS/MS analysis.</p></sec><sec id="s4-6"><title>LC-MS/MS</title><p>LC-MS/MS measurements were performed on a QExactive (QE) Plus, HF-X, and Exploris480 mass spectrometer coupled to an EasyLC 1000 and EasyLC 1200 nanoflow-HPLC, respectively (all Thermo Scientific). Peptides were fractionated on a fused silica HPLC-column tip (I.D. 75 μm, New Objective, self-packed with ReproSil-Pur 120 C18-AQ, 1.9 μm (Dr. Maisch) to a length of 20 cm) using a gradient of A (0.1% formic acid in water) and B (0.1% formic acid in 80% acetonitrile in water): samples were loaded with 0% B with a max. pressure of 800 Bar; peptides were separated by 5–30% B within 85 min with a flow rate of 250 nL/min. The spray voltage was set to 2.3 kV and the ion-transfer tube temperature to 250 °C; no sheath and auxiliary gas were used. Mass spectrometers were operated in the data-dependent mode; after each MS scan (mass range m/z=370–1750; resolution: 70’000 for QE Plus and 120’000 for HF-X and Exploris480) a maximum of ten scans for QE Plus, 12 scans HF-X and 20 scans for Exploris480 were performed using a normalized collision energy of 25%, a target value of 10’000 (QE Plus and HF-X)/5000 (Exploris480) and a resolution of 17’500 for QE Plus, 30’000 for HF-X and 60’000 for Exploris480. MS raw files were analyzed using MaxQuant (version 1.6.2.10; <xref ref-type="bibr" rid="bib23">Cox and Mann, 2008</xref>) using a Uniprot full-length <italic>S. cerevisiae</italic> database plus common contaminants such as keratins and enzymes used for in-gel digestion as reference. Carbamidomethylcysteine was set as fixed modification and protein amino-terminal acetylation, serine-, threonine-, and tyrosine- phosphorylation, and oxidation of methionine were set as variable modifications. The MS/MS tolerance was set to 20 ppm and three missed cleavages were allowed using trypsin/P as enzyme specificity. Peptide, site, and protein FDR based on a forward-reverse database were set to 0.01, the minimum peptide length was set to 7, the minimum score for modified peptides was 40, and the minimum number of peptides for identification of proteins was set to one, which must be unique. The ‘match-between-run’ option was used with a time window of 0.7 min. MaxQuant results were analyzed using Perseus (<xref ref-type="bibr" rid="bib115">Tyanova et al., 2016</xref>).</p></sec><sec id="s4-7"><title>MS data analyses</title><p>The in vivo phosphoproteome data were analyzed as described (<xref ref-type="bibr" rid="bib45">Hu et al., 2019</xref>). Briefly, measurements of the log2 fold changes on each site were combined into a random effect model, considering a priori the sites as a random effect, and including the variability among replicates by also considering the replicates as a random effect. The model assigns an average effect size and its corresponding 95% confidence interval to each site. If the confidence interval includes values of zeros, then there is no statistically significant log2 fold change, whereas if the confidence interval is above (below) zero, there is statistical evidence for upregulation (downregulation). Additionally, imputation processes were applied on both protein and phosphosite levels. Proteins that were quantified in at least two biological replicates were kept and missing values were replaced by random values of a normal distribution to mimic low abundance measurements. Both width and down shift were applied according to Perseus default settings. Phosphosites were further normalized to the protein levels. Only sites which were quantified in at least three replicates in either DMSO 5 min or 15 min were kept. Missing values in 2NM-PP1-treated samples were then replaced by the maximum likelihood estimators (MLE) imputation method (<xref ref-type="bibr" rid="bib71">Messer and Natarajan, 2008</xref>). Finally, a t-test (FDR≤0.05) was performed between DMSO and 2NM-PP1-treated samples to determine significantly changing phosphosites.</p><p>OBIKA data were analyzed using Perseus. Phosphosites which were quantified in at least three replicates in WT samples were kept. Missing values in kinase-inactive samples were replaced by either random values of a normal distribution to mimic low abundance measurements, both width and down shift were applied according to default settings, when none of five replicates was quantified, or MLE, when at least 1 of five replicates was quantified. T-tests (FDR≤0.05) were performed between WT and kinase-inactive samples to identify significantly changing sites.</p></sec><sec id="s4-8"><title>Protein purification and in vitro kinase assays</title><p>The Snf1 complex was purified from a Snf1-TEV-TAP-expressing yeast strain grown in YPD. To induce Snf1 activation, cells were washed on a filter. The same procedure was adopted to purify the catalytically inactive Snf1 complex containing the <italic>snf1<sup>T210A</sup></italic> α-subunit and the Snf1 complex, containing the C-terminally GFP-tagged Snf4 γ-subunit. Yeast cells carrying the plasmids for Sch9<sup>1-394</sup>-TEV-TAP or Sch9-TEV-TAP expression were grown overnight in SRafinose-Ura medium supplemented with 0.01% sucrose. The next day, in order to induce Sch9<sup>1-394</sup>-TEV-TAP and Sch9-TEV-TAP expression, 2% (final concentration) galactose was added to the cells when they reached OD<sub>600nm</sub>/mL of 0.2. The induction with galactose was carried out for 6 h.</p><p>For all the protein purification from yeast, cells were then collected by filtration, frozen in liquid nitrogen, and cryogenically disrupted by using a Precellys homogenizer in 10 mL of lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% NP-40, 10% glycerol, 400 mM Pefabloc, and Roche complete protease inhibitor EDTA-free). The cleared lysates were incubated for 2 h at 4 °C with IgG-coupled Dynabeads (Dynabeads M-270 Epoxy; Invitrogen, Thermo Fisher Scientific, Basel, Switzerland). The beads were washed five times with lysis buffer and proteins were eluted in TEV buffer (50 mM Tris-HCl pH 7.5, 0.5 mM EDTA,) with 2% TEV protease and stored at –80 °C after the addition of 10% glycerol.</p><p>His<sub>6</sub>-Pib2<sup>221-635</sup> variants were purified from <italic>E. coli</italic> as described in <xref ref-type="bibr" rid="bib82">Péli-Gulli et al., 2015</xref> using Ni-charged agarose beads (QIAGEN, product number 30210). Proteins were eluted in elution buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub> pH 8.0, and 200 mM imidazole) and stored at –80 °C after the addition of 10% glycerol.</p><p>In vitro radioactive kinase reactions were carried out in Snf1 kinase buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 0.5 mM DTT, and 5 mM MgAc), with 60 ng Snf1 (quantified with respect to the Snf1 subunit), 1 µg Pib2, or 80 ng Sch9 in 20 μL total volume, and started by adding the ATP Mix (3 μL [γ–32P]-ATP [Hartmann Analytic, SRP-501], 6 μL 200 µM ATP, and 1 μL Kinase Buffer 1 X) and stopped by adding SDS-PAGE sample buffer. Reactions were carried out at 30 °C and for 10 min or 30 min for Pib2 or Sch9, respectively. Proteins were separated by SDS-PAGE, stained with SYPRO Ruby (Sigma) to assess loading, and analysed using a phosphoimager (Typhoon FLA 9500; GE Healthcare). In vitro kinase assays probed by immunoblot analysis was carried out similarly as described above. The reaction was performed in 40 µL volume for 30 min at 30 °C. In the ATP mix, [γ-<sup>32</sup>P]-ATP was substituted with H<sub>2</sub>O. Finally, the reaction was probed using the following antibodies: custom-made rabbit anti-Sch9-pSer<sup>288</sup> (Eurogentec, 1:4000), and goat anti-Sch9 (GenScript, 1:1000). To assess the loading, the gel was stained with SYPRO Ruby (Sigma).</p></sec><sec id="s4-9"><title>Co-immunoprecipitation</title><p>Yeast cells expressing the indicated fusion proteins were harvested by filtration, frozen in liquid nitrogen, and cryogenically disrupted using the Precellys homogenizer in 4 mL of lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% NP-40, 10% glycerol, 400 mM Pefabloc, and Roche complete protease inhibitor EDTA-free) with the addition of 60 mM glutamine as in <xref ref-type="bibr" rid="bib116">Ukai et al., 2018</xref>. Cleared lysates were equilibrated in the same lysis buffer. For input samples, aliquots of cleared lysates were collected and denatured in presence of SDS-PAGE sample buffer. For co-immunoprecipitations, the cleared lysates were incubated for 2 h at 4 °C with prewashed anti-c-myc MagBeads (Pierce Thermo Fisher Scientific, product number 88843). After five washes with lysis buffer, beads were resuspended in 20 µL lysis buffer and denatured in presence of SDS-PAGE sample buffer. Inputs and pull-down samples were analyzed by SDS-PAGE immunoblot with mouse anti-myc (Santa Cruz, 1:10,000) and mouse anti-HA (ENZO, 1:1000) antibodies.</p></sec><sec id="s4-10"><title>Microscale thermophoresis</title><p>Microscale thermophoresis (MST) experiments were performed using a Monolith NT.115 (Nanotemper Technologies). Labeled purified Snf1 complex (0.144 µM), containing the C-terminally GFP-tagged Snf4 γ-subunit, was mixed with a twofold serial dilution (a total of 16 samples) of unlabeled 18.1 µM His<sub>6</sub>-Pib2<sup>221-635</sup> in elution buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub> pH 8.0, 200 mM imidazole, and 10% glycerol) or with unlabeled 0.118 µM Sch9<sup>1-394</sup> in elution buffer (50 mM Tris-HCl pH 8.0, 0.5 mM EDTA, and 10% glycerol). Samples were loaded into Monolith NT.115 Capillaries and MST measurements were performed using 20% laser power setting at 30 °C. Experiments were performed in triplicates and data were fitted using the <italic>K</italic><sub>d</sub> model of the MO.Affinity Analysis software (Nanotemper Technologies). The dissociation constant <italic>K</italic><sub>d</sub> was obtained by plotting the bound fraction against the logarithm of ligand concentration.</p></sec><sec id="s4-11"><title>Cell lysate preparation and immunoblot analyses</title><p>Cell lysates were prepared similarly as described in <xref ref-type="bibr" rid="bib40">Hatakeyama et al., 2019</xref>. After denaturation at 98 °C for 5 min, samples were loaded on SDS-PAGE and transferred onto nitrocellulose membranes. After 1 h blocking with blocking buffer (5% milk powder in tris-buffered saline), membranes were immunoblotted with the following primary antibodies: rabbit anti-Adh1 (Calbiochem, product number 126745; 1:200,000 dilution), rabbit anti-Sch9-pThr<sup>737</sup> (De Virgilio lab, 1:10,000 dilution), rabbit anti-Sch9-pSer<sup>288</sup> (Rospert lab, 1:4000 dilution), goat anti-Sch9 (De Virgilio lab, 1:1000 dilution), rabbit anti-AMPK-pThr<sup>172</sup> (Cell Signal, product number 2535 S, 1:1000 dilution) to detect the phosphorylation of Snf1-Thr<sup>210</sup>, mouse anti-His<sub>6</sub> (Sigma, product number H1029, 1:1000 dilution) to detect total levels of Snf1, anti-ACC1-pSer<sup>79</sup> (Thermo Fisher Scientific, product number PA5-17564, 1:500 dilution), and mouse anti-GFP (Roche, product number 11814460001, 1:3000 dilution). After 3 washes, the membranes were incubated with anti-mouse (BIO-RAD, product number 170–6516; 1:3000 dilution), rabbit (BIO-RAD, product number 170–6515; 1:3000 dilution), or goat (BIO-RAD, product number 5160–2104; 1:3000 dilution) secondary antibodies conjugated with horseradish peroxidase, washed again for three times, and developed with ECL (GE Healthcare).</p></sec><sec id="s4-12"><title>Statistical analyses</title><p>Statistical significance was determined by three or more independent biological replicates, by using Student’s t-test analysis, performed with GraphPad Prism 9.0. Unpaired Student’s t-test was used for the comparison of normalized data. Values with a p-value (or FDR where indicated) lower than 0.05 were considered significantly different. In the figure legends, the number of independent replicas, method used to express the variability, specific statistical tests, and significance are indicated.</p><p><xref ref-type="fig" rid="fig2">Figures 2</xref>—<xref ref-type="fig" rid="fig6">6</xref></p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Validation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Formal analysis, Validation, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Validation, Methodology, Writing - original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Strains, plasmids and oligonucleotides used in this study.</title></caption><media xlink:href="elife-84319-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Significantly in vivo and in vitro regulated phosphosites.</title></caption><media xlink:href="elife-84319-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-84319-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1-6 and figure supplements. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD037381.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Dengjel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Snf1/AMPK fine-tunes TORC1 signaling in response to glucose starvation</data-title><source>PRIDE</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD037381">PXD037381</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Riko Hatakeyama and Dieter Kressler for plasmids, Malika Jaquenoud for technical assistance, Marie-Pierre Péli-Gulli for carefully reading the manuscript and guidance with microscopy, Roberto Pagliarin for the kind gift of the 2NM-PP1 inhibitor, Sebastien Leon and Andrew Capaldi for constructive criticism based on the preprint version of this article, and Jeremy Thorner for pointing out the mechanistic aspects of Ypk1 regulation. This work was supported by the Canton of Fribourg (to J D and C D V), the Swiss National Science Foundation (310030_166474/184671 to CDV, 310030_184781 to JD, and 316030_177088 to JD and CDV), FWO-Vlaanderen (G069413, G0C7222N) and KU Leuven (C14/17/063, C14/21/095) to JW. We also acknowledge financial support from the Italian Ministry of University and Research (MUR) through grants 2020-ATE-0329 and Dipartimenti di Eccellenza 2017 to the University of Milano-Bicocca, Department of Biotechnology and Biosciences (to FT and PC) and from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through Project-ID 403222702 - SFB 1381, TP B08 (to SR) and RO 1028/5–2 (to SR).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>V</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mtor signaling in cellular and organismal energetics</article-title><source>Current Opinion in Cell Biology</source><volume>33</volume><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2014.12.001</pub-id><pub-id pub-id-type="pmid">25554914</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvaro</surname><given-names>CG</given-names></name><name><surname>Aindow</surname><given-names>A</given-names></name><name><surname>Thorner</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Differential phosphorylation provides a switch to control how α-arrestin Rod1 down-regulates mating pheromone response in <italic>Saccharomyces cerevisiae</italic></article-title><source>Genetics</source><volume>203</volume><fpage>299</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.186122</pub-id><pub-id pub-id-type="pmid">26920760</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anandapadamanaban</surname><given-names>M</given-names></name><name><surname>Masson</surname><given-names>GR</given-names></name><name><surname>Perisic</surname><given-names>O</given-names></name><name><surname>Berndt</surname><given-names>A</given-names></name><name><surname>Kaufman</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>CM</given-names></name><name><surname>Santhanam</surname><given-names>B</given-names></name><name><surname>Rogala</surname><given-names>KB</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name><name><surname>Williams</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Architecture of human RAG GTPase heterodimers and their complex with mTORC1</article-title><source>Science</source><volume>366</volume><fpage>203</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1126/science.aax3939</pub-id><pub-id pub-id-type="pmid">31601764</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arakel</surname><given-names>EC</given-names></name><name><surname>Huranova</surname><given-names>M</given-names></name><name><surname>Estrada</surname><given-names>AF</given-names></name><name><surname>Rau</surname><given-names>EM</given-names></name><name><surname>Spang</surname><given-names>A</given-names></name><name><surname>Schwappach</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dissection of GTPase-activating proteins reveals functional asymmetry in the COPI coat of budding yeast</article-title><source>Journal of Cell Science</source><volume>132</volume><elocation-id>jcs232124</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.232124</pub-id><pub-id pub-id-type="pmid">31331965</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Peled</surname><given-names>L</given-names></name><name><surname>Schweitzer</surname><given-names>LD</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Ragulator is a GEF for the RAG GTPases that signal amino acid levels to mTORC1</article-title><source>Cell</source><volume>150</volume><fpage>1196</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.07.032</pub-id><pub-id pub-id-type="pmid">22980980</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Peled</surname><given-names>L</given-names></name><name><surname>Chantranupong</surname><given-names>L</given-names></name><name><surname>Cherniack</surname><given-names>AD</given-names></name><name><surname>Chen</surname><given-names>WW</given-names></name><name><surname>Ottina</surname><given-names>KA</given-names></name><name><surname>Grabiner</surname><given-names>BC</given-names></name><name><surname>Spear</surname><given-names>ED</given-names></name><name><surname>Carter</surname><given-names>SL</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A tumor suppressor complex with gap activity for the RAG GTPases that signal amino acid sufficiency to mTORC1</article-title><source>Science</source><volume>340</volume><fpage>1100</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1126/science.1232044</pub-id><pub-id pub-id-type="pmid">23723238</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batth</surname><given-names>TS</given-names></name><name><surname>Francavilla</surname><given-names>C</given-names></name><name><surname>Olsen</surname><given-names>JV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics</article-title><source>Journal of Proteome Research</source><volume>13</volume><fpage>6176</fpage><lpage>6186</lpage><pub-id pub-id-type="doi">10.1021/pr500893m</pub-id><pub-id pub-id-type="pmid">25338131</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>T</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors</article-title><source>Nature</source><volume>402</volume><fpage>689</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1038/45287</pub-id><pub-id pub-id-type="pmid">10604478</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertram</surname><given-names>PG</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Carvalho</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>T-F</given-names></name><name><surname>Ai</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>XFS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Convergence of TOR-nitrogen and Snf1-glucose signaling pathways onto Gln3</article-title><source>Molecular and Cellular Biology</source><volume>22</volume><fpage>1246</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.4.1246-1252.2002</pub-id><pub-id pub-id-type="pmid">11809814</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname><given-names>M</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>Bonfils</surname><given-names>G</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Urban</surname><given-names>J</given-names></name><name><surname>Sturgill</surname><given-names>TW</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The vam6 GEF controls TORC1 by activating the ego complex</article-title><source>Molecular Cell</source><volume>35</volume><fpage>563</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.06.033</pub-id><pub-id pub-id-type="pmid">19748353</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeckstaens</surname><given-names>M</given-names></name><name><surname>Merhi</surname><given-names>A</given-names></name><name><surname>Llinares</surname><given-names>E</given-names></name><name><surname>Van Vooren</surname><given-names>P</given-names></name><name><surname>Springael</surname><given-names>JY</given-names></name><name><surname>Wintjens</surname><given-names>R</given-names></name><name><surname>Marini</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Identification of a novel regulatory mechanism of nutrient transport controlled by TORC1-npr1-amu1/par32</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005382</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005382</pub-id><pub-id pub-id-type="pmid">26172854</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>RW</given-names></name><name><surname>Jordahl</surname><given-names>EM</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Hedayati</surname><given-names>S</given-names></name><name><surname>Barsouk</surname><given-names>H</given-names></name><name><surname>Ozbaki-Yagan</surname><given-names>N</given-names></name><name><surname>Chiang</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>O’Donnell</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Torc1 signaling controls the stability and function of α-arrestins aly1 and aly2</article-title><source>Biomolecules</source><volume>12</volume><elocation-id>533</elocation-id><pub-id pub-id-type="doi">10.3390/biom12040533</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>KA</given-names></name><name><surname>Vaga</surname><given-names>S</given-names></name><name><surname>Dombek</surname><given-names>KM</given-names></name><name><surname>Fang</surname><given-names>F</given-names></name><name><surname>Palmisano</surname><given-names>S</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phosphoproteomic analysis identifies proteins involved in transcription-coupled mRNA decay as targets of Snf1 signaling</article-title><source>Science Signaling</source><volume>7</volume><elocation-id>ra64</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2005000</pub-id><pub-id pub-id-type="pmid">25005228</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>AS</given-names></name><name><surname>Soto Diaz</surname><given-names>S</given-names></name><name><surname>Van Vooren</surname><given-names>P</given-names></name><name><surname>Godard</surname><given-names>P</given-names></name><name><surname>Marini</surname><given-names>AM</given-names></name><name><surname>Boeckstaens</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pib2-dependent feedback control of the TORC1 signaling network by the Npr1 kinase</article-title><source>IScience</source><volume>20</volume><fpage>415</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.isci.2019.09.025</pub-id><pub-id pub-id-type="pmid">31622882</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buerger</surname><given-names>C</given-names></name><name><surname>DeVries</surname><given-names>B</given-names></name><name><surname>Stambolic</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Localization of Rheb to the endomembrane is critical for its signaling function</article-title><source>Biochemical and Biophysical Research Communications</source><volume>344</volume><fpage>869</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.03.220</pub-id><pub-id pub-id-type="pmid">16631613</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carling</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The AMP-activated protein kinase cascade -- a unifying system for energy control</article-title><source>Trends in Biochemical Sciences</source><volume>29</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2003.11.005</pub-id><pub-id pub-id-type="pmid">14729328</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrashekarappa</surname><given-names>DG</given-names></name><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ligand binding to the AMP-activated protein kinase active site mediates protection of the activation loop from dephosphorylation</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.422659</pub-id><pub-id pub-id-type="pmid">23184934</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Malia</surname><given-names>PC</given-names></name><name><surname>Hatakeyama</surname><given-names>R</given-names></name><name><surname>Nicastro</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Péli-Gulli</surname><given-names>M-P</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Eskes</surname><given-names>E</given-names></name><name><surname>Stefan</surname><given-names>CJ</given-names></name><name><surname>Winderickx</surname><given-names>J</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Ungermann</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Torc1 determines fab1 lipid kinase function at signaling endosomes and vacuoles</article-title><source>Current Biology</source><volume>31</volume><fpage>297</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.10.026</pub-id><pub-id pub-id-type="pmid">33157024</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherkasova</surname><given-names>VA</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Translational control by TOR and Tap42 through dephosphorylation of eIF2alpha kinase GCN2</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>859</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1101/gad.1069003</pub-id><pub-id pub-id-type="pmid">12654728</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherkasova</surname><given-names>V</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Snf1 promotes phosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 by activating GCN2 and inhibiting phosphatases Glc7 and Sit4</article-title><source>Molecular and Cellular Biology</source><volume>30</volume><fpage>2862</fpage><lpage>2873</lpage><pub-id pub-id-type="doi">10.1128/MCB.00183-10</pub-id><pub-id pub-id-type="pmid">20404097</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coccetti</surname><given-names>P</given-names></name><name><surname>Nicastro</surname><given-names>R</given-names></name><name><surname>Tripodi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Conventional and emerging roles of the energy sensor snf1/AMPK in <italic>Saccharomyces cerevisiae</italic></article-title><source>Microbial Cell</source><volume>5</volume><fpage>482</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.15698/mic2018.11.655</pub-id><pub-id pub-id-type="pmid">30483520</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowles</surname><given-names>CR</given-names></name><name><surname>Odorizzi</surname><given-names>G</given-names></name><name><surname>Payne</surname><given-names>GS</given-names></name><name><surname>Emr</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The AP-3 adaptor complex is essential for cargo-selective transport to the yeast vacuole</article-title><source>Cell</source><volume>91</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)80013-1</pub-id><pub-id pub-id-type="pmid">9335339</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title><source>Nature Biotechnology</source><volume>26</volume><fpage>1367</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id><pub-id pub-id-type="pmid">19029910</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>WA</given-names></name><name><surname>Edelman</surname><given-names>AM</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast Snf1, and mammalian calmodulin-dependent protein kinase I</article-title><source>FEBS Letters</source><volume>361</volume><fpage>191</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(95)00172-6</pub-id><pub-id pub-id-type="pmid">7698321</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deroover</surname><given-names>S</given-names></name><name><surname>Ghillebert</surname><given-names>R</given-names></name><name><surname>Broeckx</surname><given-names>T</given-names></name><name><surname>Winderickx</surname><given-names>J</given-names></name><name><surname>Rolland</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Trehalose-6-phosphate synthesis controls yeast gluconeogenesis downstream and independent of SNF1</article-title><source>FEMS Yeast Research</source><volume>16</volume><elocation-id>fow036</elocation-id><pub-id pub-id-type="doi">10.1093/femsyr/fow036</pub-id><pub-id pub-id-type="pmid">27189362</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The essence of yeast quiescence</article-title><source>FEMS Microbiology Reviews</source><volume>36</volume><fpage>306</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2011.00287.x</pub-id><pub-id pub-id-type="pmid">21658086</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demetriades</surname><given-names>C</given-names></name><name><surname>Doumpas</surname><given-names>N</given-names></name><name><surname>Teleman</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2</article-title><source>Cell</source><volume>156</volume><fpage>786</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.01.024</pub-id><pub-id pub-id-type="pmid">24529380</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeVit</surname><given-names>MJ</given-names></name><name><surname>Johnston</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of <italic>Saccharomyces cerevisiae</italic></article-title><source>Current Biology</source><volume>9</volume><fpage>1231</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(99)80503-x</pub-id><pub-id pub-id-type="pmid">10556086</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dibble</surname><given-names>CC</given-names></name><name><surname>Elis</surname><given-names>W</given-names></name><name><surname>Menon</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Klekota</surname><given-names>J</given-names></name><name><surname>Asara</surname><given-names>JM</given-names></name><name><surname>Finan</surname><given-names>PM</given-names></name><name><surname>Kwiatkowski</surname><given-names>DJ</given-names></name><name><surname>Murphy</surname><given-names>LO</given-names></name><name><surname>Manning</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tbc1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1</article-title><source>Molecular Cell</source><volume>47</volume><fpage>535</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.06.009</pub-id><pub-id pub-id-type="pmid">22795129</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubouloz</surname><given-names>F</given-names></name><name><surname>Deloche</surname><given-names>O</given-names></name><name><surname>Wanke</surname><given-names>V</given-names></name><name><surname>Cameroni</surname><given-names>E</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The TOR and ego protein complexes orchestrate microautophagy in yeast</article-title><source>Molecular Cell</source><volume>19</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.05.020</pub-id><pub-id pub-id-type="pmid">15989961</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eraso</surname><given-names>P</given-names></name><name><surname>Mazón</surname><given-names>MJ</given-names></name><name><surname>Portillo</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Yeast protein kinase Ptk2 localizes at the plasma membrane and phosphorylates in vitro the C-terminal peptide of the H+-ATPase</article-title><source>Biochimica et Biophysica Acta</source><volume>1758</volume><fpage>164</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2006.01.010</pub-id><pub-id pub-id-type="pmid">16510118</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estruch</surname><given-names>F</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Two homologous zinc finger genes identified by multicopy suppression in a Snf1 protein kinase mutant of <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular and Cellular Biology</source><volume>13</volume><fpage>3872</fpage><lpage>3881</lpage><pub-id pub-id-type="doi">10.1128/mcb.13.7.3872-3881.1993</pub-id><pub-id pub-id-type="pmid">8321194</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Generoso</surname><given-names>WC</given-names></name><name><surname>Gottardi</surname><given-names>M</given-names></name><name><surname>Oreb</surname><given-names>M</given-names></name><name><surname>Boles</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Simplified CRISPR-Cas genome editing for <italic>Saccharomyces cerevisiae</italic></article-title><source>Journal of Microbiological Methods</source><volume>127</volume><fpage>203</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.mimet.2016.06.020</pub-id><pub-id pub-id-type="pmid">27327211</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghillebert</surname><given-names>R</given-names></name><name><surname>Swinnen</surname><given-names>E</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Vandesteene</surname><given-names>L</given-names></name><name><surname>Ramon</surname><given-names>M</given-names></name><name><surname>Norga</surname><given-names>K</given-names></name><name><surname>Rolland</surname><given-names>F</given-names></name><name><surname>Winderickx</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The AMPK/SNF1/snrk1 fuel gauge and energy regulator: structure, function and regulation</article-title><source>The FEBS Journal</source><volume>278</volume><fpage>3978</fpage><lpage>3990</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08315.x</pub-id><pub-id pub-id-type="pmid">21883929</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nutrient sensing and TOR signaling in yeast and mammals</article-title><source>The EMBO Journal</source><volume>36</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.15252/embj.201696010</pub-id><pub-id pub-id-type="pmid">28096180</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ampk and TOR: the yin and yang of cellular nutrient sensing and growth control</article-title><source>Cell Metabolism</source><volume>31</volume><fpage>472</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.01.015</pub-id><pub-id pub-id-type="pmid">32130880</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goossens</surname><given-names>A</given-names></name><name><surname>de La Fuente</surname><given-names>N</given-names></name><name><surname>Forment</surname><given-names>J</given-names></name><name><surname>Serrano</surname><given-names>R</given-names></name><name><surname>Portillo</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Regulation of yeast H (+) -ATPase by protein kinases belonging to a family dedicated to activation of plasma membrane transporters</article-title><source>Molecular and Cellular Biology</source><volume>20</volume><fpage>7654</fpage><lpage>7661</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.20.7654-7661.2000</pub-id><pub-id pub-id-type="pmid">11003661</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwinn</surname><given-names>DM</given-names></name><name><surname>Shackelford</surname><given-names>DB</given-names></name><name><surname>Egan</surname><given-names>DF</given-names></name><name><surname>Mihaylova</surname><given-names>MM</given-names></name><name><surname>Mery</surname><given-names>A</given-names></name><name><surname>Vasquez</surname><given-names>DS</given-names></name><name><surname>Turk</surname><given-names>BE</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Ampk phosphorylation of raptor mediates a metabolic checkpoint</article-title><source>Molecular Cell</source><volume>30</volume><fpage>214</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.03.003</pub-id><pub-id pub-id-type="pmid">18439900</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardie</surname><given-names>DG</given-names></name><name><surname>Ross</surname><given-names>FA</given-names></name><name><surname>Hawley</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Ampk: a nutrient and energy sensor that maintains energy homeostasis</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>13</volume><fpage>251</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1038/nrm3311</pub-id><pub-id pub-id-type="pmid">22436748</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatakeyama</surname><given-names>R</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Jaquenoud</surname><given-names>M</given-names></name><name><surname>Garcia Osuna</surname><given-names>GM</given-names></name><name><surname>Sardu</surname><given-names>A</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Spatially distinct pools of TORC1 balance protein homeostasis</article-title><source>Molecular Cell</source><volume>73</volume><fpage>325</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.10.040</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatakeyama</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Pib2 as an emerging master regulator of yeast TORC1</article-title><source>Biomolecules</source><volume>11</volume><elocation-id>1489</elocation-id><pub-id pub-id-type="doi">10.3390/biom11101489</pub-id><pub-id pub-id-type="pmid">34680122</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedbacker</surname><given-names>K</given-names></name><name><surname>Townley</surname><given-names>R</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cyclic AMP-dependent protein kinase regulates the subcellular localization of Snf1-Sip1 protein kinase</article-title><source>Molecular and Cellular Biology</source><volume>24</volume><fpage>1836</fpage><lpage>1843</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.5.1836-1843.2004</pub-id><pub-id pub-id-type="pmid">14966266</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedbacker</surname><given-names>K</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Snf1/Ampk pathways in yeast</article-title><source>Frontiers in Bioscience</source><volume>13</volume><fpage>2408</fpage><lpage>2420</lpage><pub-id pub-id-type="doi">10.2741/2854</pub-id><pub-id pub-id-type="pmid">17981722</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzig</surname><given-names>S</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ampk: guardian of metabolism and mitochondrial homeostasis</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>19</volume><fpage>121</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.95</pub-id><pub-id pub-id-type="pmid">28974774</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Raucci</surname><given-names>S</given-names></name><name><surname>Jaquenoud</surname><given-names>M</given-names></name><name><surname>Hatakeyama</surname><given-names>R</given-names></name><name><surname>Stumpe</surname><given-names>M</given-names></name><name><surname>Rohr</surname><given-names>R</given-names></name><name><surname>Reggiori</surname><given-names>F</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multilayered control of protein turnover by TORC1 and Atg1</article-title><source>Cell Reports</source><volume>28</volume><fpage>3486</fpage><lpage>3496</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.08.069</pub-id><pub-id pub-id-type="pmid">31553916</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Sankar</surname><given-names>DS</given-names></name><name><surname>Vu</surname><given-names>B</given-names></name><name><surname>Leytens</surname><given-names>A</given-names></name><name><surname>Vionnet</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Stumpe</surname><given-names>M</given-names></name><name><surname>Martínez-Martínez</surname><given-names>E</given-names></name><name><surname>Stork</surname><given-names>B</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ulk1 phosphorylation of striatin activates protein phosphatase 2A and autophagy</article-title><source>Cell Reports</source><volume>36</volume><elocation-id>109762</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109762</pub-id><pub-id pub-id-type="pmid">34592149</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes Hallett</surname><given-names>JE</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Capaldi</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Snf1/Ampk promotes the formation of Kog1/Raptor-bodies to increase the activation threshold of TORC1 in budding yeast</article-title><source>eLife</source><volume>4</volume><elocation-id>e09181</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.09181</pub-id><pub-id pub-id-type="pmid">26439012</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoki</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2003">2003a</year><article-title>Rheb gtpase is a direct target of TSC2 GAP activity and regulates mtor signaling</article-title><source>Genes Dev</source><volume>17</volume><fpage>1829</fpage><lpage>1834</lpage><pub-id pub-id-type="doi">10.1101/gad.1110003</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoki</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2003">2003b</year><article-title>TSC2 mediates cellular energy response to control cell growth and survival</article-title><source>Cell</source><volume>115</volume><elocation-id>577</elocation-id><pub-id pub-id-type="doi">10.1016/s0092-8674(03)00929-2</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janke</surname><given-names>C</given-names></name><name><surname>Magiera</surname><given-names>MM</given-names></name><name><surname>Rathfelder</surname><given-names>N</given-names></name><name><surname>Taxis</surname><given-names>C</given-names></name><name><surname>Reber</surname><given-names>S</given-names></name><name><surname>Maekawa</surname><given-names>H</given-names></name><name><surname>Moreno-Borchart</surname><given-names>A</given-names></name><name><surname>Doenges</surname><given-names>G</given-names></name><name><surname>Schwob</surname><given-names>E</given-names></name><name><surname>Schiebel</surname><given-names>E</given-names></name><name><surname>Knop</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes</article-title><source>Yeast</source><volume>21</volume><fpage>947</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1002/yea.1142</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>N</given-names></name><name><surname>Mao</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Tevzadze</surname><given-names>G</given-names></name><name><surname>Kauffman</surname><given-names>EJ</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Bridges</surname><given-names>D</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Saltiel</surname><given-names>AR</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name><name><surname>Weisman</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Roles for PI(3,5)P<sub>2</sub> in nutrient sensing through TORC1</article-title><source>Mol. Biol. Cell</source><volume>25</volume><fpage>1171</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1091/mbc.E14-01-0021</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahlhofer</surname><given-names>J</given-names></name><name><surname>Leon</surname><given-names>S</given-names></name><name><surname>Teis</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The ⍺-arrestin family of ubiquitin ligase adaptors links metabolism with selective endocytosis</article-title><source>Biol. Cell</source><volume>113</volume><fpage>183</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1111/boc.202000137</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanshin</surname><given-names>E</given-names></name><name><surname>Giguère</surname><given-names>S</given-names></name><name><surname>Jing</surname><given-names>C</given-names></name><name><surname>Tyers</surname><given-names>M</given-names></name><name><surname>Thibault</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Machine learning of global phosphoproteomic profiles enables discrimination of direct versus indirect kinase substrates</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>16</volume><fpage>786</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1074/mcp.M116.066233</pub-id><pub-id pub-id-type="pmid">28265048</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>S</given-names></name><name><surname>Urban</surname><given-names>J</given-names></name><name><surname>Piccolis</surname><given-names>M</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondrial genomic dysfunction causes dephosphorylation of Sch9 in the yeast <italic>Saccharomyces cerevisiae</italic></article-title><source>Eukaryotic Cell</source><volume>10</volume><fpage>1367</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1128/EC.05157-11</pub-id><pub-id pub-id-type="pmid">21841122</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Cunningham</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A LAPF/phafin1-like protein regulates TORC1 and lysosomal membrane permeabilization in response to endoplasmic reticulum membrane stress</article-title><source>Molecular Biology of the Cell</source><volume>26</volume><fpage>4631</fpage><lpage>4645</lpage><pub-id pub-id-type="doi">10.1091/mbc.E15-08-0581</pub-id><pub-id pub-id-type="pmid">26510498</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>A</given-names></name><name><surname>Buford</surname><given-names>TD</given-names></name><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Cooper</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Differing responses of GAT1 and Gln3 phosphorylation and localization to rapamycin and methionine sulfoximine treatment in <italic>Saccharomyces cerevisiae</italic></article-title><source>FEMS Yeast Research</source><volume>6</volume><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1111/j.1567-1364.2006.00031.x</pub-id><pub-id pub-id-type="pmid">16487345</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laplante</surname><given-names>M</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mtor signaling in growth control and disease</article-title><source>Cell</source><volume>149</volume><fpage>274</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.03.017</pub-id><pub-id pub-id-type="pmid">22500797</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laussel</surname><given-names>C</given-names></name><name><surname>Albanèse</surname><given-names>V</given-names></name><name><surname>García-Rodríguez</surname><given-names>FJ</given-names></name><name><surname>Ballin</surname><given-names>A</given-names></name><name><surname>Defenouillère</surname><given-names>Q</given-names></name><name><surname>Léon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>2-Deoxyglucose transiently inhibits yeast AMPK signaling and triggers glucose transporter endocytosis, potentiating the drug toxicity</article-title><source>PLOS Genetics</source><volume>18</volume><elocation-id>e1010169</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1010169</pub-id><pub-id pub-id-type="pmid">35951639</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Jeschke</surname><given-names>GR</given-names></name><name><surname>Roelants</surname><given-names>FM</given-names></name><name><surname>Thorner</surname><given-names>J</given-names></name><name><surname>Turk</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Reciprocal phosphorylation of yeast glycerol-3-phosphate dehydrogenases in adaptation to distinct types of stress</article-title><source>Molecular and Cellular Biology</source><volume>32</volume><fpage>4705</fpage><lpage>4717</lpage><pub-id pub-id-type="doi">10.1128/MCB.00897-12</pub-id><pub-id pub-id-type="pmid">22988299</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>NXY</given-names></name><name><surname>Kaczmarek</surname><given-names>A</given-names></name><name><surname>Hoque</surname><given-names>A</given-names></name><name><surname>Davie</surname><given-names>E</given-names></name><name><surname>Ngoei</surname><given-names>KRW</given-names></name><name><surname>Morrison</surname><given-names>KR</given-names></name><name><surname>Smiles</surname><given-names>WJ</given-names></name><name><surname>Forte</surname><given-names>GM</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Lie</surname><given-names>S</given-names></name><name><surname>Dite</surname><given-names>TA</given-names></name><name><surname>Langendorf</surname><given-names>CG</given-names></name><name><surname>Scott</surname><given-names>JW</given-names></name><name><surname>Oakhill</surname><given-names>JS</given-names></name><name><surname>Petersen</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mtorc1 directly inhibits AMPK to promote cell proliferation under nutrient stress</article-title><source>Nature Metabolism</source><volume>2</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/s42255-019-0157-1</pub-id><pub-id pub-id-type="pmid">31993556</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>GY</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mtor at the nexus of nutrition, growth, ageing and disease</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>21</volume><fpage>183</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0199-y</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Jacinto</surname><given-names>E</given-names></name><name><surname>Wullschleger</surname><given-names>S</given-names></name><name><surname>Lorberg</surname><given-names>A</given-names></name><name><surname>Crespo</surname><given-names>JL</given-names></name><name><surname>Bonenfant</surname><given-names>D</given-names></name><name><surname>Oppliger</surname><given-names>W</given-names></name><name><surname>Jenoe</surname><given-names>P</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control</article-title><source>Molecular Cell</source><volume>10</volume><fpage>457</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(02)00636-6</pub-id><pub-id pub-id-type="pmid">12408816</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Target of rapamycin (TOR) in nutrient signaling and growth control</article-title><source>Genetics</source><volume>189</volume><fpage>1177</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.133363</pub-id><pub-id pub-id-type="pmid">22174183</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Ortiz-Vega</surname><given-names>S</given-names></name><name><surname>Yonezawa</surname><given-names>K</given-names></name><name><surname>Avruch</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Rheb binds and regulates the mTOR kinase</article-title><source>Current Biology</source><volume>15</volume><fpage>702</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.02.053</pub-id><pub-id pub-id-type="pmid">15854902</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J-Y</given-names></name><name><surname>Lin</surname><given-names>Y-Y</given-names></name><name><surname>Sheu</surname><given-names>J-C</given-names></name><name><surname>Wu</surname><given-names>J-T</given-names></name><name><surname>Lee</surname><given-names>F-J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>M-I</given-names></name><name><surname>Chiang</surname><given-names>F-T</given-names></name><name><surname>Tai</surname><given-names>T-Y</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Tsai</surname><given-names>K-S</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Chuang</surname><given-names>L-M</given-names></name><name><surname>Boeke</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Acetylation of yeast AMPK controls intrinsic aging independently of caloric restriction</article-title><source>Cell</source><volume>146</volume><fpage>969</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.07.044</pub-id><pub-id pub-id-type="pmid">21906795</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludin</surname><given-names>K</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Glucose-regulated interaction of a regulatory subunit of protein phosphatase 1 with the snf1 protein kinase in <italic>Saccharomyces cerevisiae</italic></article-title><source>PNAS</source><volume>95</volume><fpage>6245</fpage><lpage>6250</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.11.6245</pub-id><pub-id pub-id-type="pmid">9600950</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maqani</surname><given-names>N</given-names></name><name><surname>Fine</surname><given-names>RD</given-names></name><name><surname>Shahid</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Enriquez-Hesles</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Spontaneous mutations in cyc8 and mig1 suppress the short chronological lifespan of budding yeast lacking snf1/AMPK</article-title><source>Microbial Cell</source><volume>5</volume><fpage>233</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.15698/mic2018.05.630</pub-id><pub-id pub-id-type="pmid">29796388</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>FV</given-names></name><name><surname>Heath</surname><given-names>R</given-names></name><name><surname>Underwood</surname><given-names>E</given-names></name><name><surname>Sanders</surname><given-names>MJ</given-names></name><name><surname>Carmena</surname><given-names>D</given-names></name><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Leiper</surname><given-names>FC</given-names></name><name><surname>Xiao</surname><given-names>B</given-names></name><name><surname>Jing</surname><given-names>C</given-names></name><name><surname>Walker</surname><given-names>PA</given-names></name><name><surname>Haire</surname><given-names>LF</given-names></name><name><surname>Ogrodowicz</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>SR</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name><name><surname>Gamblin</surname><given-names>SJ</given-names></name><name><surname>Carling</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Adp regulates Snf1, the <italic>Saccharomyces cerevisiae</italic> homolog of AMP-activated protein kinase</article-title><source>Cell Metabolism</source><volume>14</volume><fpage>707</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.09.009</pub-id><pub-id pub-id-type="pmid">22019086</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Regulation of snf1 kinase activation requires phosphorylation of threonine 210 by an upstream kinase as well as a distinct step mediated by the snf4 subunit</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>36460</fpage><lpage>36466</lpage><pub-id pub-id-type="doi">10.1074/jbc.M104418200</pub-id><pub-id pub-id-type="pmid">11486005</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melick</surname><given-names>CH</given-names></name><name><surname>Jewell</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Regulation of mTORC1 by upstream stimuli</article-title><source>Genes</source><volume>11</volume><elocation-id>989</elocation-id><pub-id pub-id-type="doi">10.3390/genes11090989</pub-id><pub-id pub-id-type="pmid">32854217</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>K</given-names></name><name><surname>Natarajan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Maximum likelihood, multiple imputation and regression calibration for measurement error adjustment</article-title><source>Statistics in Medicine</source><volume>27</volume><fpage>6332</fpage><lpage>6350</lpage><pub-id pub-id-type="doi">10.1002/sim.3458</pub-id><pub-id pub-id-type="pmid">18937275</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>AH</given-names></name><name><surname>Hatakeyama</surname><given-names>R</given-names></name><name><surname>Kimmig</surname><given-names>P</given-names></name><name><surname>Arter</surname><given-names>M</given-names></name><name><surname>Peter</surname><given-names>M</given-names></name><name><surname>Matos</surname><given-names>J</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Kornmann</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Functional mapping of yeast genomes by saturated transposition</article-title><source>eLife</source><volume>6</volume><elocation-id>e23570</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.23570</pub-id><pub-id pub-id-type="pmid">28481201</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nada</surname><given-names>S</given-names></name><name><surname>Hondo</surname><given-names>A</given-names></name><name><surname>Kasai</surname><given-names>A</given-names></name><name><surname>Koike</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Uchiyama</surname><given-names>Y</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes</article-title><source>The EMBO Journal</source><volume>28</volume><fpage>477</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.308</pub-id><pub-id pub-id-type="pmid">19177150</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicastro</surname><given-names>R</given-names></name><name><surname>Tripodi</surname><given-names>F</given-names></name><name><surname>Gaggini</surname><given-names>M</given-names></name><name><surname>Castoldi</surname><given-names>A</given-names></name><name><surname>Reghellin</surname><given-names>V</given-names></name><name><surname>Nonnis</surname><given-names>S</given-names></name><name><surname>Tedeschi</surname><given-names>G</given-names></name><name><surname>Coccetti</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Snf1 phosphorylates adenylate cyclase and negatively regulates protein kinase A-dependent transcription in <italic>Saccharomyces cerevisiae</italic></article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>24715</fpage><lpage>24726</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.658005</pub-id><pub-id pub-id-type="pmid">26309257</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicastro</surname><given-names>R</given-names></name><name><surname>Sardu</surname><given-names>A</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The architecture of the RAG GTPase signaling network</article-title><source>Biomolecules</source><volume>7</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.3390/biom7030048</pub-id><pub-id pub-id-type="pmid">28788436</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novarina</surname><given-names>D</given-names></name><name><surname>Guerra</surname><given-names>P</given-names></name><name><surname>Milias-Argeitis</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Vacuolar localization via the N-terminal domain of sch9 is required for TORC1-dependent phosphorylation and downstream signal transduction</article-title><source>Journal of Molecular Biology</source><volume>433</volume><elocation-id>167326</elocation-id><pub-id pub-id-type="doi">10.1016/j.jmb.2021.167326</pub-id><pub-id pub-id-type="pmid">34695378</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Donnell</surname><given-names>AF</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ampk-Mediated regulation of alpha-arrestins and protein trafficking</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>515</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20030515</pub-id><pub-id pub-id-type="pmid">30691068</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>JV</given-names></name><name><surname>Blagoev</surname><given-names>B</given-names></name><name><surname>Gnad</surname><given-names>F</given-names></name><name><surname>Macek</surname><given-names>B</given-names></name><name><surname>Kumar</surname><given-names>C</given-names></name><name><surname>Mortensen</surname><given-names>P</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks</article-title><source>Cell</source><volume>127</volume><fpage>635</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.09.026</pub-id><pub-id pub-id-type="pmid">17081983</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostling</surname><given-names>J</given-names></name><name><surname>Ronne</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Negative control of the Mig1p repressor by snf1p-dependent phosphorylation in the absence of glucose</article-title><source>European Journal of Biochemistry</source><volume>252</volume><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.1998.2520162.x</pub-id><pub-id pub-id-type="pmid">9523726</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Amino acid deprivation inhibits TORC1 through a gtpase-activating protein complex for the RAG family gtpase gtr1</article-title><source>Science Signaling</source><volume>6</volume><elocation-id>ra42</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2004112</pub-id><pub-id pub-id-type="pmid">23716719</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>SEACing the gap that negociates TORC1 activation: evolutionary conservation of RAG gtpase regulation</article-title><source>Cell Cycle</source><volume>12</volume><fpage>2948</fpage><lpage>2952</lpage><pub-id pub-id-type="doi">10.4161/cc.26000</pub-id><pub-id pub-id-type="pmid">23974112</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>Sardu</surname><given-names>A</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Raucci</surname><given-names>S</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Amino acids stimulate TORC1 through lst4-lst7, a GTPase-activating protein complex for the RAG family GTPase gtr2</article-title><source>Cell Reports</source><volume>13</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.08.059</pub-id><pub-id pub-id-type="pmid">26387955</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>TR</given-names></name><name><surname>Laplante</surname><given-names>M</given-names></name><name><surname>Thoreen</surname><given-names>CC</given-names></name><name><surname>Sancak</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>SA</given-names></name><name><surname>Kuehl</surname><given-names>WM</given-names></name><name><surname>Gray</surname><given-names>NS</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Deptor is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival</article-title><source>Cell</source><volume>137</volume><fpage>873</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.03.046</pub-id><pub-id pub-id-type="pmid">19446321</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname><given-names>CS</given-names></name><name><surname>Roczniak-Ferguson</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of RAG GTPases</article-title><source>The Journal of Cell Biology</source><volume>202</volume><fpage>1107</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1083/jcb.201307084</pub-id><pub-id pub-id-type="pmid">24081491</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrenko</surname><given-names>N</given-names></name><name><surname>Chereji</surname><given-names>RV</given-names></name><name><surname>McClean</surname><given-names>MN</given-names></name><name><surname>Morozov</surname><given-names>AV</given-names></name><name><surname>Broach</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Noise and interlocking signaling pathways promote distinct transcription factor dynamics in response to different stresses</article-title><source>Molecular Biology of the Cell</source><volume>24</volume><fpage>2045</fpage><lpage>2057</lpage><pub-id pub-id-type="doi">10.1091/mbc.E12-12-0870</pub-id><pub-id pub-id-type="pmid">23615444</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>H</given-names></name><name><surname>Penning</surname><given-names>R</given-names></name><name><surname>Fitzpatrick</surname><given-names>MA</given-names></name><name><surname>Garrigues</surname><given-names>LB</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>MacGillavry</surname><given-names>HD</given-names></name><name><surname>Hoogenraad</surname><given-names>CC</given-names></name><name><surname>Heck</surname><given-names>AJR</given-names></name><name><surname>Altelaar</surname><given-names>AFM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Robust, sensitive, and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons</article-title><source>Journal of Proteome Research</source><volume>16</volume><fpage>728</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00753</pub-id><pub-id pub-id-type="pmid">28107008</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powis</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Crystal structure of the ego1-ego2-ego3 complex and its role in promoting RAG GTPase-dependent TORC1 signaling</article-title><source>Cell Research</source><volume>25</volume><fpage>1043</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1038/cr.2015.86</pub-id><pub-id pub-id-type="pmid">26206314</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powis</surname><given-names>K</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Conserved regulators of RAG gtpases orchestrate amino acid-dependent TORC1 signaling</article-title><source>Cell Discovery</source><volume>2</volume><elocation-id>15049</elocation-id><pub-id pub-id-type="doi">10.1038/celldisc.2015.49</pub-id><pub-id pub-id-type="pmid">27462445</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prouteau</surname><given-names>M</given-names></name><name><surname>Desfosses</surname><given-names>A</given-names></name><name><surname>Sieben</surname><given-names>C</given-names></name><name><surname>Bourgoint</surname><given-names>C</given-names></name><name><surname>Lydia Mozaffari</surname><given-names>N</given-names></name><name><surname>Demurtas</surname><given-names>D</given-names></name><name><surname>Mitra</surname><given-names>AK</given-names></name><name><surname>Guichard</surname><given-names>P</given-names></name><name><surname>Manley</surname><given-names>S</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Torc1 organized in inhibited domains (toroids) regulate TORC1 activity</article-title><source>Nature</source><volume>550</volume><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1038/nature24021</pub-id><pub-id pub-id-type="pmid">28976958</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ptacek</surname><given-names>J</given-names></name><name><surname>Devgan</surname><given-names>G</given-names></name><name><surname>Michaud</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Fasolo</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Jona</surname><given-names>G</given-names></name><name><surname>Breitkreutz</surname><given-names>A</given-names></name><name><surname>Sopko</surname><given-names>R</given-names></name><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name><name><surname>Rachidi</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>S-J</given-names></name><name><surname>Mah</surname><given-names>AS</given-names></name><name><surname>Meng</surname><given-names>L</given-names></name><name><surname>Stark</surname><given-names>MJR</given-names></name><name><surname>Stern</surname><given-names>DF</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Tyers</surname><given-names>M</given-names></name><name><surname>Andrews</surname><given-names>B</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Schweitzer</surname><given-names>B</given-names></name><name><surname>Predki</surname><given-names>PF</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Global analysis of protein phosphorylation in yeast</article-title><source>Nature</source><volume>438</volume><fpage>679</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1038/nature04187</pub-id><pub-id pub-id-type="pmid">16319894</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinke</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>McCaffery</surname><given-names>JM</given-names></name><name><surname>Yates</surname><given-names>J</given-names></name><name><surname>Aronova</surname><given-names>S</given-names></name><name><surname>Chu</surname><given-names>S</given-names></name><name><surname>Fairclough</surname><given-names>S</given-names></name><name><surname>Iverson</surname><given-names>C</given-names></name><name><surname>Wedaman</surname><given-names>KP</given-names></name><name><surname>Powers</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Tor complex 1 includes a novel component, tco89p (ypl180w), and cooperates with ssd1p to maintain cellular integrity in <italic>Saccharomyces cerevisiae</italic></article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>14752</fpage><lpage>14762</lpage><pub-id pub-id-type="doi">10.1074/jbc.M313062200</pub-id><pub-id pub-id-type="pmid">14736892</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogala</surname><given-names>KB</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Kedir</surname><given-names>JF</given-names></name><name><surname>Abu-Remaileh</surname><given-names>M</given-names></name><name><surname>Bianchi</surname><given-names>LF</given-names></name><name><surname>Bottino</surname><given-names>AMS</given-names></name><name><surname>Dueholm</surname><given-names>R</given-names></name><name><surname>Niehaus</surname><given-names>A</given-names></name><name><surname>Overwijn</surname><given-names>D</given-names></name><name><surname>Fils</surname><given-names>A-CP</given-names></name><name><surname>Zhou</surname><given-names>SX</given-names></name><name><surname>Leary</surname><given-names>D</given-names></name><name><surname>Laqtom</surname><given-names>NN</given-names></name><name><surname>Brignole</surname><given-names>EJ</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structural basis for the docking of mTORC1 on the lysosomal surface</article-title><source>Science</source><volume>366</volume><fpage>468</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1126/science.aay0166</pub-id><pub-id pub-id-type="pmid">31601708</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ptc1 protein phosphatase 2C contributes to glucose regulation of SNF1/AMP-activated protein kinase (AMPK) in <italic>Saccharomyces cerevisiae</italic></article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>31052</fpage><lpage>31058</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.503763</pub-id><pub-id pub-id-type="pmid">24019512</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saliba</surname><given-names>E</given-names></name><name><surname>Evangelinos</surname><given-names>M</given-names></name><name><surname>Gournas</surname><given-names>C</given-names></name><name><surname>Corrillon</surname><given-names>F</given-names></name><name><surname>Georis</surname><given-names>I</given-names></name><name><surname>Andre</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The yeast H<sup>+</sup>-atpase pma1 promotes rag/gtr-dependent TORC1 activation in response to H<sup>+</sup>-coupled nutrient uptake</article-title><source>eLife</source><volume>7</volume><elocation-id>e31981</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.31981</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancak</surname><given-names>Y</given-names></name><name><surname>Thoreen</surname><given-names>CC</given-names></name><name><surname>Peterson</surname><given-names>TR</given-names></name><name><surname>Lindquist</surname><given-names>RA</given-names></name><name><surname>Kang</surname><given-names>SA</given-names></name><name><surname>Spooner</surname><given-names>E</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pras40 is an insulin-regulated inhibitor of the mTORC1 protein kinase</article-title><source>Molecular Cell</source><volume>25</volume><fpage>903</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.03.003</pub-id><pub-id pub-id-type="pmid">17386266</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancak</surname><given-names>Y</given-names></name><name><surname>Bar-Peled</surname><given-names>L</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name><name><surname>Markhard</surname><given-names>AL</given-names></name><name><surname>Nada</surname><given-names>S</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids</article-title><source>Cell</source><volume>141</volume><fpage>290</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.02.024</pub-id><pub-id pub-id-type="pmid">20381137</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>P</given-names></name><name><surname>Alms</surname><given-names>GR</given-names></name><name><surname>Haystead</surname><given-names>TA</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Regulatory interactions between the Reg1-Glc7 protein phosphatase and the Snf1 protein kinase</article-title><source>Molecular and Cellular Biology</source><volume>20</volume><fpage>1321</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.4.1321-1328.2000</pub-id><pub-id pub-id-type="pmid">10648618</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>BE</given-names></name><name><surname>Levin</surname><given-names>RS</given-names></name><name><surname>Hertz</surname><given-names>NT</given-names></name><name><surname>Maures</surname><given-names>TJ</given-names></name><name><surname>Schoof</surname><given-names>ML</given-names></name><name><surname>Hollstein</surname><given-names>PE</given-names></name><name><surname>Benayoun</surname><given-names>BA</given-names></name><name><surname>Banko</surname><given-names>MR</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name><name><surname>Brunet</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Identification of AMPK phosphorylation sites reveals a network of proteins involved in cell invasion and facilitates large-scale substrate prediction</article-title><source>Cell Metabolism</source><volume>22</volume><fpage>907</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.09.009</pub-id><pub-id pub-id-type="pmid">26456332</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>JW</given-names></name><name><surname>Norman</surname><given-names>DG</given-names></name><name><surname>Hawley</surname><given-names>SA</given-names></name><name><surname>Kontogiannis</surname><given-names>L</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate</article-title><source>Journal of Molecular Biology</source><volume>317</volume><fpage>309</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1006/jmbi.2001.5316</pub-id><pub-id pub-id-type="pmid">11902845</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>RJ</given-names></name><name><surname>Bardeesy</surname><given-names>N</given-names></name><name><surname>Manning</surname><given-names>BD</given-names></name><name><surname>Lopez</surname><given-names>L</given-names></name><name><surname>Kosmatka</surname><given-names>M</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The LKB1 tumor suppressor negatively regulates mTOR signaling</article-title><source>Cancer Cell</source><volume>6</volume><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2004.06.007</pub-id><pub-id pub-id-type="pmid">15261145</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>K</given-names></name><name><surname>Choe</surname><given-names>A</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Intersubunit crosstalk in the RAG GTPase heterodimer enables mTORC1 to respond rapidly to amino acid availability</article-title><source>Molecular Cell</source><volume>68</volume><fpage>552</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.09.026</pub-id><pub-id pub-id-type="pmid">29056322</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinoda</surname><given-names>J</given-names></name><name><surname>Kikuchi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Rod1, an arrestin-related protein, is phosphorylated by Snf1-kinase in <italic>Saccharomyces cerevisiae</italic></article-title><source>Biochemical and Biophysical Research Communications</source><volume>364</volume><fpage>258</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.09.134</pub-id><pub-id pub-id-type="pmid">17949685</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirra</surname><given-names>MK</given-names></name><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name><name><surname>Arndt</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A chemical genomics study identifies Snf1 as a repressor of GCN4 translation</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>35889</fpage><lpage>35898</lpage><pub-id pub-id-type="doi">10.1074/jbc.M805325200</pub-id><pub-id pub-id-type="pmid">18955495</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>FC</given-names></name><name><surname>Davies</surname><given-names>SP</given-names></name><name><surname>Wilson</surname><given-names>WA</given-names></name><name><surname>Carling</surname><given-names>D</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The Snf1 kinase complex from <italic>Saccharomyces cerevisiae</italic> phosphorylates the transcriptional repressor protein Mig1p in vitro at four sites within or near regulatory domain 1</article-title><source>FEBS Letters</source><volume>453</volume><fpage>219</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/s0014-5793(99)00725-5</pub-id><pub-id pub-id-type="pmid">10403407</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stracka</surname><given-names>D</given-names></name><name><surname>Jozefczuk</surname><given-names>S</given-names></name><name><surname>Rudroff</surname><given-names>F</given-names></name><name><surname>Sauer</surname><given-names>U</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Nitrogen source activates TOR (target of rapamycin) complex 1 via glutamine and independently of Gtr/Rag proteins</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>25010</fpage><lpage>25020</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.574335</pub-id><pub-id pub-id-type="pmid">25063813</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>A</given-names></name><name><surname>Wallace</surname><given-names>RL</given-names></name><name><surname>Wellington</surname><given-names>R</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Capaldi</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multilayered regulation of TORC1-body formation in budding yeast</article-title><source>Molecular Biology of the Cell</source><volume>30</volume><fpage>400</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1091/mbc.E18-05-0297</pub-id><pub-id pub-id-type="pmid">30485160</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Gable</surname><given-names>AL</given-names></name><name><surname>Nastou</surname><given-names>KC</given-names></name><name><surname>Lyon</surname><given-names>D</given-names></name><name><surname>Kirsch</surname><given-names>R</given-names></name><name><surname>Pyysalo</surname><given-names>S</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Legeay</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>T</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The string database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D605</fpage><lpage>D612</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1074</pub-id><pub-id pub-id-type="pmid">33237311</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanigawa</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An in vitro TORC1 kinase assay that recapitulates the gtr-independent glutamine-responsive TORC1 activation mechanism on yeast vacuoles</article-title><source>Molecular and Cellular Biology</source><volume>37</volume><elocation-id>e00075-17</elocation-id><pub-id pub-id-type="doi">10.1128/MCB.00075-17</pub-id><pub-id pub-id-type="pmid">28483912</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanigawa</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Nagatoishi</surname><given-names>S</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Noshiro</surname><given-names>D</given-names></name><name><surname>Noda</surname><given-names>NN</given-names></name><name><surname>Tsumoto</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A glutamine sensor that directly activates TORC1</article-title><source>Communications Biology</source><volume>4</volume><elocation-id>1093</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-021-02625-w</pub-id><pub-id pub-id-type="pmid">34535752</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tee</surname><given-names>AR</given-names></name><name><surname>Manning</surname><given-names>BD</given-names></name><name><surname>Roux</surname><given-names>PP</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Blenis</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb</article-title><source>Current Biology</source><volume>13</volume><fpage>1259</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(03)00506-2</pub-id><pub-id pub-id-type="pmid">12906785</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorner</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Tor complex 2 is a master regulator of plasma membrane homeostasis</article-title><source>The Biochemical Journal</source><volume>479</volume><fpage>1917</fpage><lpage>1940</lpage><pub-id pub-id-type="doi">10.1042/BCJ20220388</pub-id><pub-id pub-id-type="pmid">36149412</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treitel</surname><given-names>MA</given-names></name><name><surname>Kuchin</surname><given-names>S</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Snf1 protein kinase regulates phosphorylation of the Mig1 repressor in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular and Cellular Biology</source><volume>18</volume><fpage>6273</fpage><lpage>6280</lpage><pub-id pub-id-type="doi">10.1128/MCB.18.11.6273</pub-id><pub-id pub-id-type="pmid">9774644</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Troutman</surname><given-names>KK</given-names></name><name><surname>Varlakhanova</surname><given-names>NV</given-names></name><name><surname>Tornabene</surname><given-names>BA</given-names></name><name><surname>Ramachandran</surname><given-names>R</given-names></name><name><surname>Ford</surname><given-names>MGJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Conserved pib2 regions have distinct roles in TORC1 regulation at the vacuole</article-title><source>Journal of Cell Science</source><volume>135</volume><elocation-id>jcs259994</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.259994</pub-id><pub-id pub-id-type="pmid">36000409</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsun</surname><given-names>ZY</given-names></name><name><surname>Bar-Peled</surname><given-names>L</given-names></name><name><surname>Chantranupong</surname><given-names>L</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Spooner</surname><given-names>E</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The folliculin tumor suppressor is a gap for the ragc/D GTPases that signal amino acid levels to mTORC1</article-title><source>Molecular Cell</source><volume>52</volume><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.09.016</pub-id><pub-id pub-id-type="pmid">24095279</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyanova</surname><given-names>S</given-names></name><name><surname>Temu</surname><given-names>T</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The maxquant computational platform for mass spectrometry-based shotgun proteomics</article-title><source>Nature Protocols</source><volume>11</volume><fpage>2301</fpage><lpage>2319</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.136</pub-id><pub-id pub-id-type="pmid">27809316</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ukai</surname><given-names>H</given-names></name><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Kira</surname><given-names>S</given-names></name><name><surname>Oikawa</surname><given-names>Y</given-names></name><name><surname>May</surname><given-names>AI</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Gtr/ego-independent TORC1 activation is achieved through a glutamine-sensitive interaction with pib2 on the vacuolar membrane</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007334</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007334</pub-id><pub-id pub-id-type="pmid">29698392</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname><given-names>J</given-names></name><name><surname>Soulard</surname><given-names>A</given-names></name><name><surname>Huber</surname><given-names>A</given-names></name><name><surname>Lippman</surname><given-names>S</given-names></name><name><surname>Mukhopadhyay</surname><given-names>D</given-names></name><name><surname>Deloche</surname><given-names>O</given-names></name><name><surname>Wanke</surname><given-names>V</given-names></name><name><surname>Anrather</surname><given-names>D</given-names></name><name><surname>Ammerer</surname><given-names>G</given-names></name><name><surname>Riezman</surname><given-names>H</given-names></name><name><surname>Broach</surname><given-names>JR</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Sch9 is a major target of TORC1 in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular Cell</source><volume>26</volume><fpage>663</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.04.020</pub-id><pub-id pub-id-type="pmid">17560372</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Dam</surname><given-names>TJP</given-names></name><name><surname>Zwartkruis</surname><given-names>FJT</given-names></name><name><surname>Bos</surname><given-names>JL</given-names></name><name><surname>Snel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Evolution of the TOR pathway</article-title><source>Journal of Molecular Evolution</source><volume>73</volume><fpage>209</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1007/s00239-011-9469-9</pub-id><pub-id pub-id-type="pmid">22057117</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varlakhanova</surname><given-names>NV</given-names></name><name><surname>Mihalevic</surname><given-names>MJ</given-names></name><name><surname>Bernstein</surname><given-names>KA</given-names></name><name><surname>Ford</surname><given-names>MGJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Pib2 and the ego complex are both required for activation of TORC1</article-title><source>Journal of Cell Science</source><volume>130</volume><fpage>3878</fpage><lpage>3890</lpage><pub-id pub-id-type="doi">10.1242/jcs.207910</pub-id><pub-id pub-id-type="pmid">28993463</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varlakhanova</surname><given-names>NV</given-names></name><name><surname>Tornabene</surname><given-names>BA</given-names></name><name><surname>Ford</surname><given-names>MGJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Feedback regulation of TORC1 by its downstream effectors Npr1 and par32</article-title><source>Molecular Biology of the Cell</source><volume>29</volume><fpage>2751</fpage><lpage>2765</lpage><pub-id pub-id-type="doi">10.1091/mbc.E18-03-0158</pub-id><pub-id pub-id-type="pmid">30156471</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Fabrizio</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Ge</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Longo</surname><given-names>VD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, TOR, and Sch9</article-title><source>PLOS Genetics</source><volume>4</volume><elocation-id>e13</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0040013</pub-id><pub-id pub-id-type="pmid">18225956</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wierman</surname><given-names>MB</given-names></name><name><surname>Maqani</surname><given-names>N</given-names></name><name><surname>Strickler</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Caloric restriction extends yeast chronological life span by optimizing the Snf1 (AMPK) signaling pathway</article-title><source>Molecular and Cellular Biology</source><volume>37</volume><elocation-id>e00562-16</elocation-id><pub-id pub-id-type="doi">10.1128/MCB.00562-16</pub-id><pub-id pub-id-type="pmid">28373292</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>WA</given-names></name><name><surname>Hawley</surname><given-names>SA</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Glucose repression/derepression in budding yeast: Snf1 protein kinase is activated by phosphorylation under derepressing conditions, and this correlates with a high AMP: ATP ratio</article-title><source>Current Biology</source><volume>6</volume><fpage>1426</fpage><lpage>1434</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(96)00747-6</pub-id><pub-id pub-id-type="pmid">8939604</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfson</surname><given-names>RL</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The dawn of the age of amino acid sensors for the mTORC1 pathway</article-title><source>Cell Metabolism</source><volume>26</volume><fpage>301</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.07.001</pub-id><pub-id pub-id-type="pmid">28768171</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wullschleger</surname><given-names>S</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Tor signaling in growth and metabolism</article-title><source>Cell</source><volume>124</volume><fpage>471</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.01.016</pub-id><pub-id pub-id-type="pmid">16469695</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>HJ</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Dhar</surname><given-names>A</given-names></name><name><surname>Pavletich</surname><given-names>NP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanisms of mTORC1 activation by Rheb and inhibition by PRAS40</article-title><source>Nature</source><volume>552</volume><fpage>368</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1038/nature25023</pub-id><pub-id pub-id-type="pmid">29236692</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaman</surname><given-names>S</given-names></name><name><surname>Lippman</surname><given-names>SI</given-names></name><name><surname>Schneper</surname><given-names>L</given-names></name><name><surname>Slonim</surname><given-names>N</given-names></name><name><surname>Broach</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Glucose regulates transcription in yeast through a network of signaling pathways</article-title><source>Molecular Systems Biology</source><volume>5</volume><elocation-id>245</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2009.2</pub-id><pub-id pub-id-type="pmid">19225458</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarei</surname><given-names>M</given-names></name><name><surname>Sprenger</surname><given-names>A</given-names></name><name><surname>Rackiewicz</surname><given-names>M</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fast and easy phosphopeptide fractionation by combinatorial ERLIC-SCX solid-phase extraction for in-depth phosphoproteome analysis</article-title><source>Nature Protocols</source><volume>11</volume><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.134</pub-id><pub-id pub-id-type="pmid">26633130</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zbieralski</surname><given-names>K</given-names></name><name><surname>Wawrzycka</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Α-Arrestins and their functions: from yeast to human health</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>4988</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23094988</pub-id><pub-id pub-id-type="pmid">35563378</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Recent advances in understanding amino acid sensing mechanisms that regulate mTORC1</article-title><source>International Journal of Molecular Sciences</source><volume>17</volume><elocation-id>1636</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17101636</pub-id><pub-id pub-id-type="pmid">27690010</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84319.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.10.18.512649" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.18.512649"/></front-stub><body><p>This rigorous and careful study provides some of the first mechanistic insights into the way that glucose starvation triggers inhibition of TORC1 (particularly in yeast) and will serve as an important resource for those interested in AMPK/Snf1 dependent regulation of a variety of other pathways and processes. The paper also provides the clearest picture yet of the regulation of Pib2, an important but poorly understood TORC1 regulator in yeast and likely beyond. The proposed mechanism is interesting and proposes multiple ways of interaction between the two signaling cascades, and will be of interest to researchers working on mechanisms of gene regulation by signaling pathways.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84319.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.18.512649">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.10.18.512649v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Snf1/AMPK fine-tunes TORC1 signaling in response to glucose starvation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kevin Struhl as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Although no new experiments are required, there are several issues to address, and the authors should consider all the comments in the reviews (which may overlap).</p><p>1) Please comment on the apparent inconsistency of the SE and SA mutants. The authors could tone down their claims by saying that yet another layer of regulation might contribute to TORC1 silencing in the absence of Snf1 phosphorylating Pib2 and Sch9. Also, the phosphorylation of Pib2 is supposedly inhibitory, so the SE allele should be equivalent to the loss of function (indeed, the effect of the SE allele is the strongest argument that phosphorylation is inhibitory). However, the SA allele should be gain-of-function, but this doesn't seem to be the case; ie, resistant to glucose starvation.</p><p>2) Please comment on the subtlety of the impact of Snf1 on TORC1, particularly the possibility of redundant mechanisms. Perhaps there are overlapping layers of TORC1 regulation in glucose starvation (e.g. TORC1-bodies/TOROIDS and regulation of Gtr1/2).</p><p>3) Please present representative immunoblots and ideally verifying key observations with an additional robust assay (such as cleaved Sch9).</p><p>4) Please discuss the phosphoproteomic data, particularly the list of Snf1 sites, and analyze potential motifs.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors limit their analysis with PIB2 to glucose-limited conditions. Given that this protein was identified as a glutamine-responsive regulator of TORC1, it would be appropriate to address how glutamine impacts the role of the SNF1-dependent phosphorylation of PIB2. Here the question is whether SNF1 is responsible for only glucose-mediated changes or whether glutamine and glucose converge at the same positions phosphorylated by SNF1.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>To strengthen the observations of Snf1-mediated suppression of TORC1 activity via Pib2, the authors may investigate other TORC1 read-outs. Also, authors can use the Sch9 mobility shift assay as shown by Hughes Hallet et al. to validate their observations.</p><p>The physiological relevance of the proposed mechanisms by which Snf1 represses TORC1 might be investigated by analyzing the growth under low glucose media conditions.</p><p>The kinase assay in figures 4D and 5C does not show Snf1 levels. Probing for the Snf1 WT and TA will solidify the observation. Also, why purified Pib2 migrate in two bands in figure 4D?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84319.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Although no new experiments are required, there are several issues to address, and the authors should consider all the comments in the reviews (which may overlap).</p><p>1) Please comment on the apparent inconsistency of the SE and SA mutants. The authors could tone down their claims by saying that yet another layer of regulation might contribute to TORC1 silencing in the absence of Snf1 phosphorylating Pib2 and Sch9. Also, the phosphorylation of Pib2 is supposedly inhibitory, so the SE allele should be equivalent to the loss of function (indeed, the effect of the SE allele is the strongest argument that phosphorylation is inhibitory). However, the SA allele should be gain-of-function, but this doesn't seem to be the case; ie, resistant to glucose starvation.</p></disp-quote><p>We fully agree with this comment and now address it in the text, as outlined in more details in our response to point 2 of reviewer #1 below.</p><disp-quote content-type="editor-comment"><p>2) Please comment on the subtlety of the impact of Snf1 on TORC1, particularly the possibility of redundant mechanisms. Perhaps there are overlapping layers of TORC1 regulation in glucose starvation (e.g. TORC1-bodies/TOROIDS and regulation of Gtr1/2).</p></disp-quote><p>We have, throughout the entire text, rephrased the description of the role of Snf1 in TORC1 control, which is limited to a period of transient reactivation of TORC1 during</p><p>the early phase of glucose starvation. In addition, we now also discuss the Snf1-independent role of the Rag GTPases (i.e. Gtr1 and Gtr2) in mediating TORC1 inactivation and TOROID formation during acute glucose starvation.</p><disp-quote content-type="editor-comment"><p>3) Please present representative immunoblots and ideally verifying key observations with an additional robust assay (such as cleaved Sch9).</p></disp-quote><p>We have replaced the respective immunoblots (in each case an issue was raised; Figure 1A, 1B, and 5F). We have also added input controls for Snf1 in Figures 4D and 5C as requested. Regarding the NTCB-cleaved Sch9 assay, please see our answer to point 9 of reviewer #3.</p><disp-quote content-type="editor-comment"><p>4) Please discuss the phosphoproteomic data, particularly the list of Snf1 sites, and analyze potential motifs.</p></disp-quote><p>We have now analyzed, as suggested by reviewer #1 (point 1), the potential difference between early (5 min) and late (15min) responding Snf1-sites. This new analysis yielded indeed some interesting additional insight that we now discuss appropriately in the Results section (for more details please see our specific response to point 1 of reviewer #1 below).</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The authors limit their analysis with PIB2 to glucose-limited conditions. Given that this protein was identified as a glutamine-responsive regulator of TORC1, it would be appropriate to address how glutamine impacts the role of the SNF1-dependent phosphorylation of PIB2. Here the question is whether SNF1 is responsible for only glucose-mediated changes or whether glutamine and glucose converge at the same positions phosphorylated by SNF1.</p></disp-quote><p>To address the question to what extent nitrogen (including glutamine) limitation activates Snf1 when compared to glucose starvation, we subjected wild-type cells to nitrogen or glucose starvation and measured Snf1 activity by determining the levels of Snf1-Thr<sup>210</sup> and ACC1-GFP-Ser<italic><sup>79</sup></italic> phosphorylation (new Supplementary figure 1B and 1C). While glucose starvation strongly activated Snf1, the respective activation by nitrogen starvation was, albeit significant, rather moderate. Accordingly, the Snf1 activity in nitrogen-starved cells was approximately 10 times lower than the one in glucose-starved cells. Hence, Snf1 mediates to some extent nitrogen starvation signals, but glucose starvation is by far more important in this context (which is why we primarily focus on this condition here).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>To strengthen the observations of Snf1-mediated suppression of TORC1 activity via Pib2, the authors may investigate other TORC1 read-outs. Also, authors can use the Sch9 mobility shift assay as shown by Hughes Hallet et al. to validate their observations.</p></disp-quote><p>Using the anti Sch9-pThr<sup>737</sup> antibodies to assess TORC1 activity is in our view still the best currently available TORC1 readout. We have also used the proposed band-shift assays (of the NTBC-cleaved Sch9 C-terminus) in the past but realized that the quantification of TORC1 activity is less accurate. Accordingly, the Sch9 C-terminus migrates in several phospho-isoforms, not all of which rely on direct TORC1-mediated phosphorylation. For instance, Thr<sup>570</sup> is phosphorylated by Pkh1/2 (PMID: 17560372). In addition, Ser<sup>723</sup> and Ser<sup>726</sup> (formerly considered to be direct TORC1 sites; PMID: 17560372), have recently been shown to be targets of the CDK Bur1 (PMID: 35166010). Our own current studies show in fact that the latter two residues define the turn motif of Sch9 and are also targeted by the CDK Pho85-Pho80, which primes Sch9 for subsequent phosphorylation of its Thr<sup>737</sup> residue (similarly as CDC2 and GSK-3 do in mammalian S6K; PMID: 9271440, 11914378, 12586835, and 22065737). The responsiveness of these phospho-residues to rapamycin is most likely due to the activation of a phosphatase. Thus, we hope it is acceptable to use Sch9-pThr<sup>737</sup>/Sch9 levels as a TORC1 readout here.</p><disp-quote content-type="editor-comment"><p>The physiological relevance of the proposed mechanisms by which Snf1 represses TORC1 might be investigated by analyzing the growth under low glucose media conditions.</p></disp-quote><p>Please see our response to point 4 of reviewer #2.</p><disp-quote content-type="editor-comment"><p>The kinase assay in figures 4D and 5C does not show Snf1 levels. Probing for the Snf1 WT and TA will solidify the observation. Also, why purified Pib2 migrate in two bands in figure 4D?</p></disp-quote><p>We included the input levels of Snf1 in the revised Figures 4D and 5C. Notably, Pib2 gets partially degraded during the preparation, which is why there are additional degradation bands visible. We modified Figure 4D accordingly and highlighted this issue in the legend.</p></body></sub-article></article>